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Abstract
Study 1. Molecular activity of the sodium pump and membrane fatty acid 
composition in the nervous system of an endotherm and an ectotherm
In the present study, molecular activities of the sodium pump were investigated in three 
nervous tissues (brain, spinal cord and sciatic nerve) and two non-nervous tissues (kidney 
and heart) from Rattus norvegicus and Bufo marinus in relation to membrane fatty acid 
composition. Sodium pump concentration was measured by H-ouabain binding assay and 
Na+-K+-ATPase activity by ouabain-inhibited ATPase activity. Membrane fatty acid 
composition was determined on tissue phospholipid extract using gas chromatography. 
Molecular activity of the sodium pump was 5,000-10,000 ATP/min in rat tissues (with the 
exception of sciatic nerve at -1,600 ATP/min), and 1,000-1,700 ATP/min in toad tissues 
(with the exception of heart at -5,000 ATP/min). The sodium pump molecular activities in 
rat brain, spinal cord and kidney were 5.5-6.5 times those in the same tissues of toad. 
However, no significant difference was found in sciatic nerve and heart between the two 
species (P>0.05), although the values in heart were much higher than in sciatic nerve. 
Comparison of the membrane fatty acid compositions of these tissues showed that toad 
tissues contained more n-6 PUFAs while the same tissues of rat contained more n-3 
PUFAs. Among the nervous tissues, monounsaturation increased while polyunsaturation 
decreased from brain to spinal cord to sciatic nerve, along with a decrease of overall 
unsaturation. No significant correlation was detected between the sodium pump molecular 
activity and a number of parameters of membrane fatty acid composition. From the results, 
no evidence was obtained suggesting membrane fatty acid composition determines 
molecular activity of the sodium pump.
Study 2. Influence of thyroid status on molecular activity of the sodium pump and 
membrane fatty acid composition
This study aimed to examine the influence of thyroid status on sodium pump 
concentration, Na+-K+-ATPase activity and sodium pump molecular activity in relation to 
membrane fatty acid composition in three nervous tissues (brain, spinal cord and sciatic 
nerve) and two non-nervous tissues (kidney and heart). Rats of hyper-, eu- and hypothyroid
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statuses were developed by constant infusion with T4, saline and PTU respectively. Plasma 
hormone concentrations were determined by RIA. Other determinations were similar to 
study 1. All the three nervous tissues displayed unresponsiveness (or resistance) to change 
in systemic thyroid status in terms of sodium pump concentration, Na+-K+-ATPase activity 
and sodium pump molecular activity. In kidney and heart, sodium pump concentration 
increased significantly in hyperthyroidism while decreased significantly in 
hypothyroidism. Parallel changes were observed in kidney and heart regarding Na+-K+- 
ATPase activity. As far as molecular activity of the sodium pump is concerned, no 
significantly variation was found between different thyroid statuses in kidney and heart 
apart from an increase in hypothyroidism in kidney (P<0.05). On the other hand, different 
thyroid statuses resulted in slight variations in membrane fatty acid composition in these 
tissues. The ratio of C20:4n-6/C18:2n-6 increased in hyper- and decreased in 
hypothyroidism in all the tissues. In nervous tissues, only C20:4n-6/C18:2n-6 ratio was 
positively correlated to plasma thyroid hormone concentrations. In contrast, positive 
correlation was found in kidney and heart between thyroid hormone concentrations and 
sodium pump concentration, Na+-K+-ATPase activity and 20:4n-6/C18:2n-6 ratio. A 
negative correlation was found in kidney between sodium pump molecular activity and 
thyroid hormone concentrations. These results suggest thyroid hormones modify molecular 
activity of the sodium pump other than regulation at the level of transcription. However, no 
evidence was obtained suggesting thyroid hormones achieve regulation of sodium pump 
via changing membrane fatty acid composition.
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Chapter 1 Introduction
1.1 Sodium pump & membrane fatty acid composition
1.1.1 Structure & function o f the sodium pump
The sodium pump (or Na+-K+-ATPase) is a multi-component transmembrane protein. Its 
function is to maintain the transmembrane gradients of Na+ and K+ by hydrolysis of ATP. 
One monomer of the sodium pump is composed of a catalytic a  subunit, a smaller 
glycosylated (3 subunit and a y subunit. It is still not clear whether the sodium pump exists 
in monomeric, dimeric or tetrameric form, or a regulated mixture of them (Craig 1982; 
Linnertz et al 1998; Tsuda et al 1998). It is generally believed that the a  subunit consists 
of 10 transmembrane (TM) helices with the second intracellular loop between TM4 and 
TM5 involved in the transport and enzymatic process. The glycosylated P subunit has a 
single TM. It is mainly involved in stabilization and membrane insertion. Function of the y 
subuint is still controversial. A schematic representation of the structure of the sodium 
pump with its topology and major functional domains is shown in figure 1.1 (Fambrough 
et al 1994).
Studies on dynamics have revealed that the sodium pump translocates three Na+ out of and 
two K+ into the cell by the hydrolysis of one ATP (Glynn & Karlish 1975). The 
maintenance of Na+ and K+ gradients across plasma membrane is essential for functioning 
and survival of living cells. Numerous cellular processes are linked to transmembrane Na+ 
and K+ gradients, either directly or indirectly. Sodium pump functions as the central piece 
in the complex cross-membrane transport system formed by channels, exchangers and co­
transporters (as illustrated in figure 1.2). Consistent with its vital importance, sodium pump 
activity forms an important part of cellular metabolism. For example, in excitable tissues 
such as the nervous system and heart where transmembrane fluxes of ions make up the 
action potential, and in kidney and intestine where transmembrane absorption and 
secretion are extensive, sodium pump activity accounts for 20-40% of the total energy 
consumed by cellular metabolism (Rolfe & Brown 1997).
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Figure 1.1 Structure of the sodium pump
3 N a  ■+■
A schematic demonstration of the structure of Na+-K+-ATPase. The a  subunit is proposed to span 
plasma membrane 10 times and have both amino and carboxyl termini in the cytosol. The (3 subunit 
spans the plasma membrane a single time and has its amino terminus in the cytosol. Approximate 
positions are shown for the translocation and phosphorylation domains of the a  subunit and the 3 
disulfide bonds and glycosylation sites of the (3 subunit. (From Fambrough et al 1994).
Figure 1.2 Transmembrane transport system
Cellular processes associated with transmembrane Na+ and K+ gradients.
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1.1.2 Na+-K+-ATPase in endo- and ectotherms
Generally, the total cellular metabolism of mammalian tissues is 4-9 times that of 
equivalent tissues of ectotherms even at the same body temperature (Hulbert & Else 1981; 
Brand et al 1991). However, when the proportions of various cellular processes that make 
up cellular metabolism were examined, it was demonstrated that distribution among these 
processes remained consistent for the same tissues from mammals and from ectothermic 
species (Rolfe & Brown 1997; Hulbert & Else 1981; Brand et al 1991). Consequently, the 
energy consumption of sodium pump is 4~9 times higher in mammals than in ectotherms 
(Hulbert & Else 1981).
There are a couple of factors that could lead to higher sodium pump activity in 
endotherms, namely, greater transmembrane gradients of Na+ and K+ or greater passive 
permeability of plasma membrane to Na+ and K+. However, information available on 
transmembrane Na+ and K+ gradients rules out the first possibility (Withers 1992). On the 
other hand, when the plasma membrane permeability to Na+ and K+ in liver and kidney 
was compared between a mammal (rat) and an ectotherm (lizard), the rat plasma 
membrane was shown to be 1.6-3.2 times more permeable to K+ than the lizard, and 8 
times more permeable to Na+ (Else & Hulbert 1987; Hulbert & Else 1990). Therefore, the 
higher passive permeability of mammal plasma membrane to Na+ and K+ is likely to be the 
reason for the higher sodium pump activity seen in mammals.
Similarly, the in vitro activity of Na+-K+-ATPase is also higher in mammal tissues than in 
the same tissues of ectotherms (Else et al 1996). This variation in sodium pump and Na+- 
K+-ATPase activity could be achieved by difference in number of the sodium pump or in 
the turnover rate of individual Na+-K+-ATPase, or a combination of the two. In a recent 
study on sodium pump molecular activity, a measurement of the maximal capacity of a 
single sodium pump molecule by dividing in vitro Na+-K+-ATPase activity with sodium 
pump concentration, multiple tissues were compared from different animals including both 
endotherms and ectotherms (Else et al 1996). It was found that the variation in molecular 
activity of the sodium pump, rather than the difference in sodium pump concentration, was
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the main reason for the difference in Na+-K+-ATPase activity between endotherms and 
ectotherms.
1.1.3 Membrane as a pacemaker o f cellular metabolism
When metabolic activities are studied at cellular and subcellular levels, a small number of 
processes appear to be the dominant contributors. These processes include: the energy 
consumed by the mitochondrial proton leak, the energy consumed by Na+-K+-ATPase, 
Ca2+-ATPase and other ion pumps to maintain cross-membrane ion gradients, and the 
energy consumed to synthesize proteins and other substances (Rolfe & Brown 1997). It is 
evident that a significant proportion of cellular metabolism is associated with membranes 
(e.g. inner mitochondrial membrane and plasma membrane). Since the distribution of 
energy consumption is consistent among different species, these cellular processes must 
change in harmony. Therefore, one factor (or a number of factors) could be conceivably in 
control of these processes. Recently, membranes have been suggested to act as the 
“pacemaker” of cellular metabolism (Hulbert & Else 1999). This hypothesis states that 
membranes regulate the activity of membrane-associated proteins by protein-lipid 
interactions. As the potential pacemaker of cellular metabolism, membranes achieve this 
regulation by altering their composition and consequently physical properties. The altered 
membrane properties would lead to changes in the activity of membrane-associated 
proteins. For example, when a sugar transporter protein from human erythrocyte was 
reconstituted into phospholipid bilayers of different compositions, changes in all the 
components of phospholipid molecule were shown to modify the transporter activity with a 
range of effects (Carruthers & Melchior 1984; Tefft et al 1986). Similarly, lipid 
composition of the vesicles into which the purified Na+ channel proteins were reconstituted 
would determine the binding property and functional state of the channel (Catterall 1984).
The basic structure of membranes is a phospholipid bilayer with hydrophilic headgroups 
facing the aqueous environment and fatty acyl tails pointing toward the center of the 
bilayer. The phospholipid molecules are in constant formation and degradation. However, 
among the large variety of phospholipids, only a few are synthesized de novo, while the 
rest are formed by the process of deacylation and reacylation. In addition, membrane-
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associated desaturases act to insert double bonds into specific positions of fatty acid chains 
(Schmid et al 1995). The properties of a membrane are determined by its composition. For 
instance, the fluidity of a membrane is determined by the unsaturation and chain length of 
the fatty acyls of its phospholipids and its cholesterol level (Hulbert 2000). On the other 
hand, polyunsaturated fatty acids (PUFAs) of n-6 and n-3 families which could insert 
double bonds into the central portion of membrane, also have significant influence on 
membrane properties (Hulbert & Else 1999). A variety of membrane properties have been 
proposed to mediate the regulation of the activities of membranous proteins by lipid 
composition. These include membrane fluidity (Calder et al 1994; Bordoni et al 1989), 
packing order of fatty acyl chains and bilayer thickness (Stubbs et al 1981; Carruthers & 
Melchior 1988), membrane dipole potential (Clarke 1997), membrane stiffness (Lundbaek 
et al 1996), hydration in the head group and interchain region (Ho et al 1994; Ho & Stubbs 
1992), and kinetic energy transmission between lipid molecules (Hulbert & Else 1999). It 
is still not clear which one or any combination of them mediates the effects of lipid 
composition on membrane protein activity.
1.1.4 Na+-K^-ATPase and membrane fatty acid composition
A recent study endorsed the idea of Na+-K+-ATPase being regulated by its membrane 
environment (Else & Wu 1999). After treating the microsomal factions of brain and kidney 
from rat and toad with detergent, the molecular activity, or the maximum enzyme activity 
of Na+-K+-ATPase decreased rapidly with detergent concentration. Sodium pump 
molecular activity, however, could be recovered by re-incorporation of sodium pump 
protein into heat-treated microsomal vesicles from the same animal. Notably, when rat 
Na+-K+-ATPase was reconstituted into the microsomes from toad, only 60-70% of the 
original was recovered. But when toad Na+-K+-ATPase was reconstituted into rat 
microsomes, the recovered molecular activity was 140% that of the original. Although this 
change in molecular activity was partially attributed to lipid incorporation, the molecular 
basis of this regulation has not been clearly defined.
When the fatty acid composition of microsomal membrane was compared between the 
same tissues from endotherms and ectotherms, significant difference was detected in the
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concentrations of polyunsaturated fatty acids (PUFA) and in the distribution of PUFAs.
For instance, markedly higher concentration of PUFAs was found in rat compared with 
toad. Notably, this difference was most evident in the PUFAs of n-3 family, predominantly 
docosahexaenoic acid (C22:6n-3) (Else & Wu 1999). Similarly, in another study where the 
phospholipid composition of mitochondrial membranes was investigated from rat and 
lizard, rat was found to have more unsaturated mitochondrial membranes containing high 
n-3 PUFAs (Brand et al 1991). These findings make membrane polyunsatuartion 
(especially concentration of n-3 PUFAs) an appealing candidate for the membrane 
regulation of metabolism (Hulbert & Else 2000).
A number of studies on Na+-K+-ATPase have observed that changing the membrane fatty 
acid composition could modulate its activity. In drug-induced diabetes, increased affinity 
of Na+-K+-ATPase for ouabain was related to altered membrane fatty acid composition 
(Gerbi & Maixent 1999). Furthermore, n-3 PUFAs have demonstrated the ability to modify 
Na+-K+-ATPase activity and its ouabain affinity. Positive correlations have been found 
between Na+-K+-ATPase activity and both C22:6n-3 and n-3 PUFA content (Gerbi et al 
1994; Ruiz-Gutierrez et al 1993). A positive correlation was also detected between Na+- 
K+-ATPase activity and the ratio of unsaturated/saturated fatty acid and unsaturation index 
of membranes (Corrocher et al 1990). These findings further support the idea that 
membrane fatty acid composition is an important component in the regulation of Na+-K+- 
ATPase by membranes.
1.2 Influence of thyroid hormones on the sodium pump and membranes
1.2.1 Thyroid hormones: structure & metabolism
Thyroid hormones are iodothyronines synthesized and secreted by the thyroid gland (or 
diffused thyroid follicles in some species) in vertebrates. In the thyroid follicles, iodination 
reactions take place in which iodine is attached to the ortho position to the phenolic 
hydroxyl group of certain tyrosine residues of thyroglobulin. Two iodothyronines, 
thyroxine (T4) and 3',3,5-triiodothyronine (T3), are released into the circulation (structures 
are shown below). The phenolic group of T3 and T4 could be ionized at different pH values
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(8.4 and 6.5 respectively), whose ionization is a major determinant of hormone 
lipophilicity. Because of this amphipathic nature, T4 and T3 strongly associate with 
membrane bilayers at suitable pH values. At physiological pH the partition coefficient 
between phospholipid membranes and the aqueous compartment is 12,000 for T4 and 
22,000 for T3 (Hillier 1970).
Thyroxine (T4) 3',3,5-triiodothyronine (T3)
After secretion, the thyroid hormones are transported around the body by a number of 
plasma proteins including thyroxine-binding globulin (TBG), transthyretin (TTR) and 
albumin (ALB). These proteins form a finely regulated, multi-component carrier system 
(Hulbert 2000). T4 predominates at the stage of secretion, while a substantial proportion of 
T3 comes from the deiodination of T4 in peripheral tissues (Hennemann 1986).
Deiodination of T4 results in the removal of iodine from the outer ring or the inner ring, 
producing T3 or reverse T3 (rT3). Further deiodination would produce three types of 
diiodothyronines (3,5-T2, 3,3/-T2, and 3/,5/-T2). Three types of deiodinase have been 
identified, namely, D l, D2, and D3 (St Germain & Galton 1997). All three enzymes are 
membranous enzymes associated with plasma membrane or endoplasmic reticulum with 
specific tissue distributions: D l is ubiquitously expressed, especially dense in liver, 
kidney, thyroid gland and central nervous system (CNS), D2 in CNS, brown adipose tissue 
and placenta, and D3 in CNS and placenta. The activities of the deiodinases are 
differentially regulated by thyroid status. D l activity in liver and kidney is stimulated in 
hyperthyroidism and inhibited in hypothyroidism (Kaplan & Utiger 1978), whereas D2 
activity is inversely related to thyroid status (Kaplan 1986), and D3 activity is regulated in 
a similar way to D l (Esfandiari et al 1992). A combination of these facts suggests the 
existence of a homeostatic enzymatic system in some tissues (such as brain) to regulate 
hormone metabolism and maintain constant T3 level. In hyperthyroidism, D2 activity in 
brain is inhibited when brain gets adequate T3 from that produced by other tissues like liver
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and kidney. In hypothyroidism, D1 activity in liver and kidney is inhibited so that enough 
T4 could be available for brain, and the increased activity of D2 in brain will keep T3 at 
constant level (Hulbert 2000). This mechanism contributes to the observed 
unresponsiveness of brain to changes in thyroid status. Although this mechanism is also 
found in brown adipose tissue, whether it exists in other tissues is not known.
1.2.2 Action o f thyroid hormones: nuclear receptor-mediated & non-nuclear mediated 
Thyroid hormones achieve their effects by binding to nuclear receptors and regulating gene 
expression, as evidenced by the changes in the concentrations of mRNAs and the encoded 
proteins (Oppenheimer et al 1987). The nuclear receptors for thyroid hormones have been 
detected in a wide range of tissues including brain, liver and kidney. These receptors have 
been identified as members of a superfamily of nuclear receptors that modulate 
transcription of the target genes (Evans 1988; Lazar 1993). Some specific DNA sequences 
that interact with thyroid receptors, known as thyroid response elements (TRE), have been 
identified (Lazar 1993, Umesono & Evans 1989). Two types of nuclear thyroid receptor 
have been characterized: TRot and TR(3, each including a couple of isoforms. The structure 
of thyroid receptors consists of a DNA-binding domain and a hormone-binding domain. 
Both the DNA-binding and the hormone-binding domains are highly conserved (Evans 
1988). The binding of thyroid hormone results in a specific conformational alteration, 
leading to stimulation or inhibition of transcription of the target genes (Glass 1996; Zamir 
et al 1997).
However, not all the effects of thyroid hormones could be explained by this nuclear 
receptor-mediated mechanism. This could be evidenced by the modification by thyroid 
hormones of activity of membrane-associated enzymes in human erythrocytes, which do 
not contain a nucleus. For instance, stimulation of Ca2+-ATPase activity and Na+-K+- 
ATPase activity by thyroid hormone was observed in erythrocytes (Davis et al 1983; 
Sutterlin et al 1984). In other studies, however, the activity of Na+-K+-ATPase and number 
of ouabain binding sites decreased in erythrocytes from hyperthyroidism and increased in 
hypothyroidism (Arumanayagam et al 1990; Ogasawara & Nishikawa 1988). Similarly, 
the time courses of a number of effects stand against the nuclear receptor-mediated
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mechanism. Their rapid emergence after hormone administration makes the transcriptional 
regulation impossible (Segal & Ingbar 1984; Davis & Davis 1993). For example, when the 
regulation of glucose uptake by thyroid hormones was studied in chick embryo heart cells, 
a biphasic stimulation was observed: an initial phase (<6hrs) involving stimulation of the 
molecular activity of existing transporters in the plasma membrane and a second phase 
(6~24hrs) involving stimulation of transcription and protein synthesis (Gordon et al 1994). 
Therefore, thyroid hormones appear to act via multiple pathways, namely, apart from the 
nuclear receptor-mediated mechanism, a plasma membrane receptor for thyroid hormone 
or a non-specific, generalized effect on membrane proteins might be involved (Gordon et 
al 1994; Arumanayagam et al 1990).
Because of their amphipathic nature, thyroid hormones could be readily incorporated into 
cell membranes as a result of physical partition. An intramembrane orientation has been 
suggested of the hormone molecules with the phenolic group toward the center of the 
bilayer and the iodine group of the inner ring facing the aqueous environment (Hulbert 
2000). Examination of cellular localization of thyroid hormones has revealed accumulation 
of hormones within membranes, including plasma membrane, mitochondrial membrane, 
endoplasmic reticulum, sarcoplasmic reticulum and nuclear envelope (Manuelidis 1972; 
Bregengaard et al 1989). This leads to the suggestion that, instead of via specific receptor 
proteins only, thyroid hormone action may also involve a membrane-mediated mechanism, 
namely, thyroid hormones change the lipid composition of a membrane, and thus its 
physical properties, which in turn result in alterations in the activities of membrane- 
associated proteins (Hulbert 2000).
1.2.3 Effects o f thyroid hormones on the composition and properties o f membranes 
Studies on hyper- and hypothyroid mammals have found significant changes in the lipid 
composition of membranes (plasma, mitochondrial, microsomal, and nuclear) from a 
variety of tissues. These include changes in both phospholipid class distribution and fatty 
acyl composition (Ruggiero et al 1984, 1989; Faas & Carter 1981, 1982; Hoch et al 1981; 
Hoch 1988). The most conspicuous and consistent change is the thyroid status-associated 
changes in the proportion of linoleic acid (C18:2n-6) and arachidonic acid (C20:4n-6). The
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former increases in hypothyroidism and decreases in hyperthyroidism, while the latter 
changes in the opposite direction, suggesting regulation of converting enzyme activities 
(including A6, A5 desaturases and elongase) by thyroid status: inhibition in 
hypothyroidism and stimulation in hyperthyroidism. These changes take place shortly 
(0.5-2.5 hrs) after the change in thyroid status so that they appear to be mediated by some 
direct effect of thyroid hormone on membrane lipids and the membrane-associated 
desaturase and elongase instead of via the nuclear mechanism. However, no correlation has 
been detected between n-3 PUFAs and thyroid status. Possibly related to the local 
homeostatic enzyme system, membrane lipid composition of brain appears resistant to 
change in thyroid status (Tacconi et al 1991).
The changes in membrane composition in association with thyroid status are manifested in 
alteration in the properties of membranes. Since the fluidity of a membrane is directly 
related to the acyl composition of its phospholipids with respect to both unsaturation and 
chain length, fluidity is the most characterized membrane property to be modified by 
thyroid status. In some studies thyroid hormones act to rigidify membranes (Beleznai et al 
1989; Parmar et al 1995), whereas in others increased fluidity was observed associated 
with hyperthyroidism, accompanied by increased unsaturation in fatty acid composition 
(Pilarska et al 1991). On the other hand, in studies of the mitochondrial inner membrane 
where the translocation of H+, another major part of cellular metabolism, takes place, 
thyroid hormone treatment leads to increased H+ leakage. This increased leakage to H+ has 
been proposed to be the consequence of thyroid hormone-induced changes in membrane 
lipid composition, especially increased polyunsaturation in the fatty acyl composition 
(Brand et al 1992).
1.2.4 Effects o f thyroid hormones on the sodium pump
It has been known since early that thyroid hormones stimulate metabolic activity (Magnus- 
Levy 1895). In mammals, a positive correlation exists between thyroid hormone level and 
basal metabolic rate (BMR). It is noteworthy that, although most metabolically active 
tissues are sensitive to stimulation by thyroid hormone, brain appears refractory to thyroid
10
status and keeps a relatively constant metabolic rate (Hulbert 2000). This may also be 
explained by the homeostatic enzyme system present in brain as previously mentioned.
Thyroid hormones increase both sodium pump activity (as measured by ouabain-inhibited 
oxygen consumption) and in vitro Na+-K+-ATPase activity (Ismail-Beigi & Edelman 1970; 
Haber & Loeb 1986; 1988). It has also been demonstrated that administration of thyroid 
hormone results in increased number of sodium pump molecules and mRNA levels, 
suggesting the involvement of increased synthesis (Ewart & Klip 1995; McDonough et al 
1988). Furthermore, the induction of sodium pump genes by thyroid hormones is isoform- 
specific. Thyroid hormone treatment selectively induces the isoform with high ouabain 
affinity, but is less effective on the low-affinity isoform (Haber & Loeb 1988; Ewart &
Klip 1995). However, after low-dose T3 treatment the sodium pump activity (measured by 
86Rb+ uptake) in rat liver increased without changing the Na+-K+-ATPase activity (Haber 
& Loeb 1986), suggesting the increase in Na+-K+-ATPase activity and sodium pump 
synthesis might be secondary responses to increased passive fluxes of Na+ and K+, the 
major determinants of sodium pump activity in vivo. This has been supported by time 
course studies of thyroid hormone-stimulated changes that the increase in active Na+, K+ 
transport was preceded by increase in passive Na+ influx and K+ efflux (Ismail-Beigi et al 
1986; Haber & Loeb 1986; Haber et al 1988; Harrison & Clausen 1998). Another fact that 
challenges the transcriptional stimulation as primary response is the lack of TREs in the 
genes of Na+-K+-ATPase subunits (Hulbert 2000).
On the other hand, when the effect of thyroid hormone was examined in a variety of 
tissues, although increased concentrations of ouabain-binding site were observed in liver, 
kidney, and skeletal muscle, hormone treatment failed to induce such a change in the 
sodium pump of brain (Lin & Akera 1978). This might also result from the homeostatic 
system for thyroid hormone metabolism present in brain (as previously discussed). In a 
study of the sodium pump in rat sciatic nerve, different thyroid statuses did not bring about 
changes in sodium pump concentration either (Kjeldsen & N0gaard 1987). Although this 
suggests that, similar to brain, sciatic nerve is resistant to changes in thyroid status, it is not 
known whether a similar homeostatic system is present in the peripheral nervous system.
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1.3 Aim & objectives
This study aims to characterize the interrelationships between thyroid hormones, molecular
activity of the sodium pump and membrane fatty acid composition. It consists of two parts:
1.3.1 Study 1. Molecular activity o f the sodium pump and membrane fatty acid 
composition in the nervous system o f an endotherm and an ectotherm
■ This study determines the Na+-K+-ATPase activity, sodium pump concentration and, 
eventually, the molecular activity of the sodium pump in both central and peripheral 
nervous tissues of one endotherm (Rattus norvegicus) and one ectotherm (Bufo 
marinus).
■ This study also analyzes the membrane fatty acid composition of these tissues.
■ Finally, this study explores the relationship between the sodium pump molecular 
activity of various tissues and the characteristics of their membrane fatty acid 
composition.
1.3.2 Study 2. Influence o f thyroid status on molecular activity o f the sodium pump and 
membrane fatty acid composition
• This study determines the effects of different thyroid status on molecular activity of the 
sodium pump in a number of tissues of rat, including both thyroid-responsive and 
thyroid-resistant.
• This study also determines the effects of different thyroid status on the membrane fatty 
acid composition of these tissues.
• Finally, this study examines the relationship between thyroid status, sodium pump 
molecular activity and membrane fatty acid composition.
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Chapter 2 Materials & Methods
2.1 Study 1. Molecular activity of the sodium pump and membrane fatty acid 
composition in the nervous system of an endotherm and an ectotherm
2.1.1 Animals
The endotherm used in this study was the laboratory rat (Rattus norvegicus, strain 
Sprague-Dawley): females, aged 6~10 week, body weight 200-350 g. All rats were 
bred in the animal house at the University of Wollongong but the parent rats originated 
from the Animal Resource Center (Perth, WA, Australia). They were maintained at 22 
± 2°C with 12/12 light:dark photoperiod and ad lib access to food (regular rat chow, 
supplied by Young Stock Feeds Ltd., NSW, Australia) and water. The ectotherm used 
in this study was the cane toad (.Bufo marinus, 140-220 g) obtained from a commercial 
supplier (Peter Douch, NQ, Australia). The toads were kept on a substratum of 
moistened paper in large plastic box (50 x 100 x 50cm) at 22 ± 2°C with free access to 
water. All procedures were performed in conformity with the National Health &
Medical Research Council Guidelines for Animal Research and approved by the 
Animal Experimentation Ethics committee of Wollongong University (No. AE95/02).
2.1.2 Materials
3H-ouabain (0.555-1.11 Tbq/mol, 1 mCi/ml, radiopurity 99.0%) dissolved in ethanol 
was obtained from NEN Life Science Products, Inc. (MA, USA). Ethanol was removed 
under a stream of nitrogen gas, and the 3H-ouabain was resuspended in distilled water 
at 200 pCi/ml. Ouabain was obtained from ICN Biomedicals Inc. (OH, USA). Na2ATP 
(special quality) was purchased from Boehringer Mannheim GmbH (Mannheim, 
Germany). Sodium deoxycholate and ammonium molybdate ((NFL)6Mo7024*4H20 ) 
were from BDH Ltd. (Poole, UK). Tissue solubilizer (Soluene -100) and liquid 
scintillation cocktail (Hionic-Fluor®) were purchased from Packard Instruments, Inc. 
(CA, USA). Medical carbogen (95% 02:5% C02) was the product of BOC Gases 
Australia Ltd. (NSW, Australia).
Analytical grade methanol, chloroform, ethyl acetate, and extra pure grade diethyl ether 
and petroleum spirit (40-60°C) were Merck products obtained from Crown Scientific
13
Pty. Ltd. (NSW, Australia). Analytical grade butylated hydroxytoluene, 14% (w/v) 
boron trifluoride-methanol, and laboratory reagent sodium hydrosulfite (approx. 80%) 
were from Sigma. All fatty acid methyl ester (FAMEs) standards were obtained from 
Sigma. Silane-treated glass wool was purchased from Alltech Associates (Aust.) Pty. 
Ltd. (NSW, Australia). Sep-Pak® silica cartridge and Sep-Pak® Florisil® cartridge were 
obtained from Waters™ Division, Millipore Corporation (MA, USA). High purity 
hydrogen, nitrogen and instrument grade synthetic air were the products of BOC Gases 
Australia Ltd. (NSW, Australia).
Nembutal® (pentobarbitone sodium) was from Boehringer Ingelheim Pty. Ltd. (NSW, 
Australia). Tricaine methane sulphonate was obtained from ICN Biomedicals Inc. (OH, 
USA). All standard chemicals were of analytical grade (Sigma, BDH products).
2.1.3 Tissue Preparation
Rats were euthanased by Nembutal® overdose (lOOmg/kg body mass, i.p.). Toads were 
anaesthetized by immersion in 0.5% tricaine methane sulphonate (MS222, pH adjusted 
to 7.4), and then sacrificed by heart removal. Brain cortex, spinal cord and sciatic nerve 
were used to represent central and peripheral nervous tissues. Kidney (cortex for rats 
and whole kidney for toads) and heart (ventricular muscle) were chosen as comparison 
because Na+-K+-ATPase in these tissues is very active and has been extensively 
studied. 3H-ouabain binding was conducted immediately after sacrifice, and the 
remaining tissues were kept at -84°C for subsequent determinations.
2.1.4 H-ouabain binding
3H-ouabain binding assay was conducted as previously described in Else et al (1996). 
After removal from the animal, the tissues were immediately cut into small pieces 
weighing 1~8 mg. The tissue biopsies were preincubated in freshly made, ice-cold K+- 
free medium (for composition see table 2.1) for 2 x 10 min to reduce tissue K content 
and minimize its interference with ouabain binding. This was followed by incubation of 
biopsies in 2 ml of 3H-ouabain labelled K+-free medium (1-2 pCi/ml) for 2 hr at
multiple ouabain concentrations ranging from 5 x 10' M to 5 x 10' M (final
• -2concentrations were achieved by addition of unlabeled ouabain). Incubation at 10 M 
ouabain was used to determine non-specific binding. Incubations were continuously
14
agitated with a constant flow of carbogen (95% 02:5% CO2) to move the incubation
medium around the tissue biopsies. Rat tissues were incubated at 37 °C and toad tissues
incubated at 25°C, their approximate body temperatures in nature. After incubation, all
• ®tissue biopsies were drained, placed on pre-moistened filter paper discs (Whatman ,
#5) in a Millipore rapid sampling manifold, followed by a washout procedure in 3 ml 
ice-cold K+-free medium for 5 x 8 min to reduce 3H-ouabain associated with 
extracellular space. All biopsies were lightly blotted, weighed immediately and placed 
into scintillation vials (each containing 200 pi of tissue solubilizer Soluene@-100) 
overnight. 3H activity (measured as disintegration per minute) was determined on a 
Wallac 1409/1411 liquid scintillation counter (Wallac Oy, Turku, Finland).
Table 2.1 Composition o f K+-free medium for 3H-ouabain binding assay
Rat (mM) Toad (mM)
NaCl 125 115
MgS04 1.2 1.4
NaHC03 25 20
NaH2P 04 1.2 3.1
CaCl2 1.3 1.3
D-Glucose 5.0 17
pH 7.4 7.1
The 3H-ouabain binding was expressed as relative uptake, i.e. 3H activity taken up per 
gram wet weight of tissue relative to the 3H activity in the incubation medium. Non­
specific uptake, determined by incubation in excess ouabain (102 M), was subtracted 
from the total uptake in the standard assay. Remaining 3H activity was assumed to 
represent specific uptake. Concentration of the sodium pump was expressed as 
picomole 3H-ouabain binding per gram tissue by multiplying the specific uptake and 
the total ouabain concentration in the medium. Values were corrected for loss of 
specifically bound 3H-ouabain during washout and radiopurity of 3H-ouabain. The 
conditions of standard assay and the correction factors were determined by a series of 
preliminary studies, as outlined below.
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2.1.4.1 Incubation time
To determine the equilibrium time of 3H-ouabain binding, tissue biopsies were 
incubated in 10~6 and 10'5 M ouabain over a period of 1~4 hrs followed by a 5 x 8 min 
washout. At both 10‘6 and 10‘5 M incubations, equilibrium of 3H-ouabain uptake was 
achieved by 2 hr for all the tissues. Similarly, non-specific uptake (determined by 
incubation at 10'2 M ouabain) also reached a steady level by 2 hr in all tissues. Figure
2.1 shows the specific 3H-ouabain uptake at 10~6 and 10'5 M ouabain (after correction 
for nonspecific binding) by each tissue of rat and toad plotted against incubation time.
It was observed that, for all the tissues, the specific binding of H-ouabain reached its 
maximum level before or at 2 hr. Therefore, 2-hr incubation was used in standard assay 
to achieve maximum specific binding and viability of tissues. It was also observed that 
specific binding decreased after 2 hr in some tissues. An likely reason appears to be 
decrease in the capacity of tissue mitochondria over time to produce ATP to 
phosphorylate the sodium pump.
Figure 2.1 Time course of specific 3H-ouabain binding in rat and toad tissues
Rat Toad
♦ 10'6 M ■ 10'5 M
(a) Brain
5000 -, 
4000 -
i i
3000 -
o
EQ. 2000 -
1000 - .  * ♦
0 --------- 1--------h
1 2 3
hours
Í
0
(b) Spinal cord
D)
Ö
EQ.
12000 -r
9000 -
6000 -  
3000 -  
0 —
0 1
í  Ï
2 3
hours
}
♦
4
4000 -i- 8000 -i
3000 -- X  6000 - Ï  *  i  1
I  ■ Ï  O) !
2000 -- 1  ■ 1  4000 -
Cl
1000 -. 2000 -
*  ♦  + ♦ 1  *  ♦ ♦
n ________ i-------- 1-------- 1-------- 1 0 -------- 1-------- 1-------- 1-------- 1
1 2 3 4 0 1 2 3 4
hours hours
16
(c) Sciatic nerve
(d) Kidney
(e) Heart
o
E
Cl
300 -r 400 -
i l l  300 - - I
200 -
I  "  I  I  ^
f  O 200 - - ■  *  i  *
4- E
100 - Q. 100 -
*  S  *  5 1  1  ♦  i
0 - -----------1-----------1---------- 1---------- 1 o -J---------- t---------- 1---------- t---------- 1
1 2 3
hours
1 2 
hours
Time course of specific 3H-ouabain uptake was investigated at 10"6 and 10'5 M ouabain over an incubation period of 
4 hrs, with 3H activity measured at 1-hr interval. Rat tissues are shown on the left and toad on the right. The values, 
expressed as pmol/g, are specific binding of 3H-ouabain after correction for nonspecific binding. It is observed that 
specific uptake approaches a saturated level by 2 hr for all the tissues. Values shown are the means of four 
determinations and SEM represented by the error bar. Specific binding at 10"6 M ouabain is represented by ♦, and 
10'5 M by ■.
2.1.4.2 Washout
The standard assay involves a washout procedure to reduce the H-ouabain non­
specifically held in extracellular space. Loss of specific 3H-ouabain binding can be 
expected during this time. To determine an appropriate washout program and correct
o 1.
for the loss of specifically bound H-ouabain, the release of H-ouabain during washout
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was investigated by incubation at 10’6 and 10~5 M ouabain for 2 hrs, followed by a 
prolonged washout of 10 x 8 min. After each wash, a 500 jal aliquot of wash media was 
collected and its H activity determined. By successively adding the H activity 
released into wash media to the 3H activity remaining in the tissue biopsies at the end 
of washout, the 3H activity remaining in the tissue biopsies at the end of each wash was 
calculated. Figure 2.2 shows the washout profile of each tissue with H activity after 
each wash expressed as percentage of the initial level.
(a) Brain
Figure 2.2 Washout profiles of 3H-ouabain binding in rat and toad tissues
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Release of 3H-ouabain during a washout of 10 x 8 min was investigated at 10~6 and 10"5 M ouabain, along with non­
specific binding determined at 10'2 M ouabain. 3H activity released in each wash was determined and successively 
added to the 3H activity remaining in the tissues at the end of the washout procedure. The washout profiles are 
shown in semi-log plot, with rat tissues on the left and toad on the right. The 3H activity at the end of each wash is 
expressed as percentage of the initial level. The washout profiles displayed a biphasic pattern of an initial rapid loss 
followed by a slow exponential release. Each point in the figure represents the mean value of four determinations 
with SEM shown by the error bar. Values for 10'6 M ouabain are illustrated by ♦, values for 10'5 M ouabain by ■, 
and values for 10'2 M ouabain by *  to represent non-specific binding.
Although the 3H activity remaining in tissue at the end of washout varied markedly 
among different tissues, the release of 3H-ouabain during washout followed a common 
biphasic pattern for all the tissues, composed of an initial rapid loss followed by a slow 
exponential release. The slow phase was assumed to represent the release of H- 
ouabain from specific binding sites. After five washes, the rapid loss of H-oubain from 
non-specific binding in extracellular space was nearly complete while the slow 
exponential release from specific binding barely started. Hence the use of 5 x 8min 
washout in the standard assay. Regression analysis was performed on the exponential 
release to determine its dissociation rate. Using this dissociation rate, the loss of 
specific binding during washout was ascertained and the correction factor was 
obtained. Dissociation rate and correction factor for each tissue of rat and toad are 
presented in table 2.2.
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Table 2.2 Dissociation rate (RD) of specifically bound 3H-ouabain after 5 x 8min 
washout and correction factor (CF) for this loss
Tissues
Rat Toad
Rd (m in1) CF Rd (m in1) CF
Kidney 1.54 x 10'3 1.21 2.03 x 10'3 1.16
Brain 2.16 x 10'3 1.20 2.00 x 10'3 1.13
Sciatic nerve 6.19 x 10'4 1.15 1.01 x 10'3 1.22
Spinal cord 2.36 x 10'3 1.25 2.40 x 10'3 1.23
Heart 2.71 x 1(T4 1.07 1.40 x 10'3 1.19
2.1.5 Na+-K f -ATPase activity
Na+-K+-ATPase activity was determined in tissue homogenate using the method of 
Akera (1984). Tissues were removed upon sacrifice and stored at -84°C until assay. 
Dilute tissue homogenates (1~5%, w/v) were prepared using a glass-glass homogenizer 
in ice-cold homogenizing medium (in mM: sucrose 250, EDTA 5, imidazole 20, 
sodium deoxycholate 2.4, at pH 7.4). Optimal dilution ratio for each tissue was 
determined by preliminary experiments to ensure a linear relationship between Na+-K+- 
ATPase activity and protein concentration. Homogenates (50-100 jrl) were 
preincubated in the assay medium (see table 2.3) with or without ouabain for 10 min at 
37°C for both species. Because previous data indicated that increasing incubation 
temperature to 37°C would not damage Na+-K+-ATPase activity in toad tissue (Else et 
al 1996), the same incubation temperature at 37°C was used for both species for the 
convenience of comparison, although it is higher than the natural temperature for cane 
toad (the Na+-K+-ATPase activities of toad tissues at 25°C and their Qi0 values are 
shown in appendix 1). The reaction was started by addition of Na2-ATP and continued 
for 15 min. The reaction was terminated by addition of 1.0 ml ice-cold 0.8 N perchloric 
acid, then the reaction mixture was centrifuged at 1,200 g for 20 min in a Hettich 
Universal 16R centrifuge (HD Scientific, Australia) at 0-4°C.
Phosphate concentration was measured using the method of Bonting et al (1961). A 
color reagent was made up by the following procedures: dissolving 1 g of ammonium 
molybdate in 80 ml of water, followed by addition of 3.3 ml 98% sulphuric acid, 
mixing thoroughly, then adding 4 g of ferrous sulphate (FeS04*7H20 )  under constant 
stirring, and finally adjusting the volume to 100 ml by distilled water (color reagent
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was used within 2 hr of preparation). 250 pi supernatant from the reaction mixture was 
added to a microcuvette containing 250 pi distilled water and 500 pi color reagent, then 
allowed to stand for 10 min to develop color. Absorbance was read at 750 nm on a 
SHIMADZU UV-1601 spectrophotometer (SHIMADZU Oceania Pty. Ltd, Australia). 
Phosphate standards ranging from 25 pl/ml to 250 pl/ml were prepared from a stock 
solution 1 mM Na2HP04.
Na+-K+-ATPase activity was defined as the ouabain-inhibited release of 
orthophosphate. Enzyme activity was expressed as micromoles of orthophosphate 
released per milligram of tissue per hour (pmol Pi/mg tissue-hr'1).
Table 2.3 Reaction mixtures for the determination of Na+-K+-ATPase activity
Mixture A Mixture B
V (ml) C (mM) V (ml) C (mM)
250 mM Tris-HCla 0.3 83.3 0.3 83.3
50 mM MgCl2 0.1 5 0.1 5
1000 mM NaCl 0.1 100 0.1 100
150 mM KC1 0.1 15 - -
50 mM NaN3 0.1 5 0.1 5
10 mM Ouabain - - 0.1 1
Tissue homogenate 0.05/0.1 variable 0.05/0.1 variable
25 mM Nar ATP 0.2 5 0.2 5
h 2o 0.05/0 0.05/0
Abbreviations: V = volume, C = concentration.
Na+-K+-ATPase activity is defined as ouabain-sensitive ATPase activity, represented by 
the difference in orthophosphate release between mixture B and mixture A. 
a: pH adjusted to 7.4 with 250 mM tris base solution.
2.1.6 Molecular activity o f the sodium pump
Molecular activity, expressed as the number of ATP used by a single Na+-K+-ATPase 
per minute, was calculated by dividing Na+-K+-ATPase activity (converted to pmol Pi/g 
tissue-min’1) with sodium pump concentration (pmol/g tissue). This definition of 
molecular activity assumes one sodium pump has one ouabain-binding site.
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2.1.7 Membrane fatty acid composition
2.1.7.1 Extraction of phospholipids & preparation of FAMES
Analysis of membrane fatty acid composition was performed on a phospholipid extract 
of tissues, which predominantly exists in membranes. Phospholipid extraction was 
conducted following the method of Folch et al (1957). Tissue samples weighing 
50-150 mg were homogenized in 12ml chloroform-methanol solution (2:1 v/v, 
containing butylated hydroxytoluene at 0.1 g/L). The homogenates were rotated on a 
tube rotator overnight at 4°C. Phase separation was accomplished by addition of 2ml 
1M H2S 0 4 followed by centrifugation at 400 g for 10 min at 4°C. The lower 
chloroform phase was extracted. To further purify the chloroform phase this procedure 
was repeated a second time. The extracted chloroform phase was dehydrated by 
addition of -100 mg sodium hydrosulfite and filtered through silane-treated glass wool. 
Phospholipids were extracted using solid-phase extraction on Sep-Pak® silica cartridge 
by the following procedure: phospholipids were eluted with 30ml methanol after 
elution of neutral lipids with 30ml ethyl acetate. The extracted phospholipids were 
transmethylated by addition of 1ml 14% (w/v) boron trifluoride-methanol and 
incubated at 85°C for 1 hr. The reaction was stopped by addition of 3ml ice-cold 
distilled water. FAMEs were extracted by 5 x 2 ml n-hexane, then filtered through Sep- 
Pak® Florisil® cartridge to remove cholesterol esters and polar contaminants. Finally, 
FAMEs were eluted with 7ml 5% (v/v) diethyl ether-petroleum spirit (40-60°C) and 
condensed under nitrogen to 1ml for analysis.
2.1.7.2 Determination of fatty acid composition
Composition of FAME in the phospholipid extracts was analyzed by gas-liquid 
chromatography. A Hewlett-Packard 5890 Series II gas chromatograph equipped with a 
7673 automatic liquid sampler (Hewlett-Packard, Palo Alto, CA, USA) was used (see 
figure 2.3). 1 pJ of sample was injected on-column into a J&W DB-23 fused silica 
capillary column 30m x 0.25mm x 0.25pm (J&W Scientific, Folson, CA, USA). High 
purity hydrogen was used as carrier gas at 40 cm/sec (measured at 150°C). The initial 
oven temperature was set to 170°C. A temperature program was employed: 170-200°C 
at 3°C/min, then 200°C for 3 min, followed by 200-250°C at 50°C/min and finally 
250°C for 2 min. The FAMEs were detected by a flame ionization detector (FID) at
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220°C with nitrogen as the makeup gas at 30 ml/min. External standards were used and 
the FAMEs in the samples were identified by comparing their retention times to those 
of standards. Contents of identifiable fatty acids were expressed as area percentage of 
the total fatty acids identified in each sample.
Figure 2.3 Hewlett-Packard 5890 Series II gas chromatograph
2.1.7.3 Parameters of fatty acid composition determined
Sums of MUFAs and PUFAs, and PUFA/MUFA ratio were calculated. Proportions 
were determined for unsaturated fatty acids of different families including n-9, n-7, n-6 
and n-3. Furthermore, unsaturation index (UI) and average chain length (avCL) were 
calculated as below:
UI = E[(percentage of each unsaturated fatty acid)(the number of double bonds 
therein)];
avCL = Z[(percentage of each fatty acid)(its chain length)]/100.
2.1.8 Statistics
Results were expressed in the form of mean ± SEM with the number of observations in 
parenthesis. Statistical significance was ascertained by two-tailed, independent-samples 
t test. Data in the form of percentage were compared after arsine transformation. 
Levene’s test was employed to check for equality of variances and normal probability
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plots to check for normality. Regressional analysis was performed and the Pearson’s 
coefficient was calculated to examine the existence of correlation. SPSS version 11.0 
(SPSS Inc., Australia) was employed.
2.2 Study 2. Influence of thyroid status on molecular activity of the sodium 
pump and membrane fatty acid composition
2.2.1 Animals
The animals used in this study were laboratory rats (Rattus norvegicus, Sprague- 
Dawley strain): females, 8-week old on arrival, body mass 221.2 ± 5.3 g (n=20). They 
were purchased from the Animal Resource Center (Perth, WA, Australia). The rats 
were maintained at 22 ± 2°C with 12/12 light:dark photoperiod and ad lib access to 
food (regular rat chow, supplied by Young Stock Feeds Ltd., NSW, Australia) and 
water throughout the study. A 2-week time of orientation was allowed before the study 
started. All procedures were performed in conformity with the National Health & 
Medical Research Council Guidelines for Animal Research and approved by the 
Animal Experimentation Ethics committee of Wollongong University (No. AE00/18).
2.2.2 Materials
L-thyroxine (T4) and 6-n-propyl-2-thiouracil (PTU) were obtained from Sigma. 
Phloretin was purchased from BIOMOL Research Laboratories, Inc. (PA, USA). 
Ketamine hydrochloride solution (at 100mg/ml) was from Parnell Laboratories (Aust.) 
Pty. Ltd. (NSW, Australia). Rompun® (xylazine hydrochloride solution at 20mg/ml) 
was from Bayer Australia Ltd. (NSW, Australia). Alzet® osmotic pumps (model 2ML2, 
volume 2145 ± 43 pi, flow rate 5.01 ± 0.26 pl/hr) were the product of ALZA 
Corporation (CA, USA) obtained through BioScientific Pty. Ltd. (NSW, Australia). 
Spectria® T3[125I] and T4[125I] RIA Kits were purchased from Orion Diagnostica 
(Espoo, Finland). EDTA-coated BD Vacutainer™ tubes (7ml, 13x100mm) were kindly 
provided as a gift by BD Preanalytical Solutions (NSW, Australia). Sterile saline and 
iodine swabs were obtained from a local pharmacist.
L-histidine from Sigma and sodium dodecyl sulphate (SDS) from BDH Ltd. (Poole, 
UK). For all other chemicals and materials necessary for 3H-ouabain binding, Na+-K+-
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ATPase activity assay and analysis of membrane fatty acid composition see section
2.1.2.
2.2.3 Establishment o f animal models for different thyroid statuses
2.2.3.1 Preparation of the osmotic pump
The rats were randomly distributed into three study groups: hyper- (n=7), eu- (n=6) and 
hypothyroid (n=7) groups. Different thyroid statuses were achieved by constant 
infusion delivered via Alzet® 2ML2 osmotic pumps for 2 weeks. The composition of 
infusion media for each group is shown in table 2.4. Osmotic pumps were filled with 
the infusion media following the instructions in the product manual. The process of 
filling was performed under sterile condition. The percentage of filling was 99.5±0.2% 
of the reservoir volume, higher than the 90% criterion specified in the manual. Before 
implantation, the filled osmotic pumps were primed by placing in sterile saline at 37°C 
overnight in order to reach a steady release rate.
Table 2.4 Compositions of the infusion media for different thyroid statuses
Groups Composition of infusion
Hyperthyroid T4 dissolved in sterile saline (at 175 mg/L, approximately 
10 pg/100g body mass.d'1) containing 0.02 M NaOH.
Euthyroid Sterile saline containing 0.02 M NaOH.
Hypothyroid PTU dissolved in sterile saline (at 17.5 g/L, approximately 
1 mg/100g body mass.d'1) containing 0.02 M NaOH.
*PTU is a commonly used antithyroid drug whose mechanism of action includes: 
preventing iodide organification by inhibiting the enzyme thyroid peroxidase which 
converts iodide (f) to iodine (F); blocking the coupling of MIT and DIT which are 
required for the formation of T3 and T4; and blocking the peripheral conversion of 
T4 to T3 (Greenspan & Dong 2000).
2.2.3.2 Implantation of the osmotic pump
The osmotic pumps were implanted subcutaneously into the rats. The operation was 
performed following the surgical procedures described in the product manual. Briefly, 
the rats were anesthetized by administration of ketamine (5 mg/100g body mass, i.p.) 
and Rompun® (1 mg/100g body mass, i.m.). The dorsal skin between scapulae was 
shaved, washed and sterilized with iodine swab. A 1~2 cm mid-scapular vertical
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incision was made. By inserting a hemostat into the incision and spreading along the 
back, a 6~7 cm long subcutaneous pocket was created. The osmotic pump was inserted 
into the pocket, with the delivery portal toward the tail to minimize the interference 
with incision healing from the delivered compounds. Finally, the incision was closed 
by wound clips and sterilized with iodine swab. After the operation, the rats were 
monitored for vital signs until full recovery. They were caged individually and checked 
daily during the following 2 weeks.
2.2.4 Tissue preparation
Brain cortex, spinal cord, sciatic nerve, kidney cortex and heart (ventricular muscle) 
were used in this study. Rats were sacrificed by means of Nembutal overdose as 
described in section 2.1.3. 2~4 ml ventricular blood was extracted before heart removal 
and injected into the EDTA-coated BD Vacutainer™ tubes. 1~2 drops of phloretin 
solution (at 100 pM, pH 11.5) was added to prevent metabolism of T3 and T4. The 
blood samples were centrifuged at 1,000 g for 10 min and plasma kept at -20°C for 
hormone level determination. 3H-ouabain binding was performed immediately after 
sacrifice. Remaining tissues were kept at -84°C for subsequent determinations.
2.2.5 Determination o f plasma concentrations o fT 3  and T4
RIA was employed to determine the total plasma contents of T3 and T4. The assay was 
performed following the manufacturer’s instructions. Briefly, triplicates of standards 
and duplicates of plasma samples were incubated at 37°C for 1 hr in tubes coated with 
monoclonal antibodies. After decanting, the 125I activity of each tube was measured on 
a 1480 Wallac Wizard® 3" automatic gamma counter (Wallac Oy, Turku, Finland) at 
10,000 counts per tube. The 125I activities of standards and plasma samples were 
converted to percentages of the 125I activity of the zero-standard. A standard curve was 
obtained by plotting the converted percentage values of standards against their 
respective hormone concentrations. Then the hormone content in each plasma sample 
was read off the standard curve according to its converted percentage value.
2.2.6 3 H-ouabain binding
Based on the results of study 1 (see section 3.2.1), 3 x 10'5 M ouabain was used in the 
incubation to achieve maximal specific binding (P>0.05 compared to the results at 5 x
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5 210 M) while maintaining maximum concentration difference from 10' M used for 
non-specific binding. Therefore, in study 2, tissue biopsies were incubated in H- 
ouabain labeled K+-free medium containing 3 x 10'5 M ouabain for 2 hr, followed by a 
5 x 8  min washout (refer to section 2.1.4).
2.2.7 Na+-Kf-ATPase activity
During the course of this project, a different method for Na+-K+-ATPase activity 
determination was introduced in this laboratory (Esmann 1988). The in vitro Na+-K+- 
ATPase activities of different tissues obtained by this method appear to be 70-230% 
higher than those obtained by the method of Akera (1984) (see section 4.2.4). In order 
to get maximum Na+-K+-ATPase activity, the method of Esmann (1988) was employed 
in study 2. Briefly, dilute tissue homogenates (2-4%, w/v) were prepared using a glass- 
glass homogenizer in ice-cold homogenizing medium (in mM: sucrose 250, EDTA 5, 
imidazole 20, at pH 7.4). SDS was used in this study as the detergent to optimize Na+- 
K+-ATPase activity. A SDS buffer was prepared (in mM: imidazole 25, ATP 3, EDTA 
2) containing SDS at 0, 0.2, 0.25, or 0.3 mg/ml for different tissues (appropriate SDS 
concentration for each tissue was determined in preliminary experiments). 150 pi of the 
SDS buffer was added slowly into 150 pi tissue homogenate under constant vortex. The 
mixture was allowed to stand for 5 min. Then 50 pi was added to the assay medium 
(see table 2.5) with or without ouabain and preincubated for 10 min at 37°C. The 
reaction was started by addition of Na2-ATP and continued for 5 min. The subsequent 
procedures were performed as in study 1 (for details see section 2.1.5).
2.2.8 Molecular activity o f the sodium pump
Molecular activity of the sodium pump was calculated as described in section 2.1.6.
2.2.9 Membrane fatty acid composition
The analysis of membrane fatty acid composition was performed as described in 
section 2.1.7.
2.2.10 Statistics
Results were expressed in the form of mean ± SEM with the number of observations in 
parenthesis. Statistical significance was ascertained by one-way ANOVA followed by
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Tukey test. Data in the form of percentage were compared after arsine transformation. 
Levene’s test was employed to check for equality of variances and normal probability 
plots to check for normality. Regressional analysis was performed and the Pearson’s 
coefficient was calculated to examine the existence of correlation. SPSS version 11.0 
(SPSS Inc., Australia) was employed.
Table 2.5 Reaction mixtures for the determination o f Na+-K+-ATPase activity (revised)
Mixture A Mixture B
V (ml) C (mM) V (ml) C (mM)
150 mM L-Histidine 0.2 30 0.2 30
40 mM MgCl2 0.1 4 0.1 4
620 mM NaCl 0.2 124 0.2 124
200 mM KC1 0.1 20 - -
10 mM Ouabain - - 0.1 1
Tissue homogenate+ 
SDS buffer
0.05 variable 0.05 variable
h 2o 0.25 0.25
30 mM Nar ATP 0.1 3 0.1 3
Abbreviations: V = volume, C = concentration.
Na+-K+-ATPase activity is defined as ouabain-sensitive ATPase activity, represented by 
the difference in orthophosphate release between mixture B and mixture A.
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Chapter 3 Molecular activity of the sodium pump and 
membrane fatty acid composition in the nervous system of an
endotherm and an ectotherm
3.1 Introduction
Mammalian tissues display higher sodium pump activity and in vitro Na+-K+-ATPase 
activity than equivalent tissues from ectotherms (Hulbert & Else 1981; Else et al 1996). 
Comparative studies have found that the elevated Na+-K+-ATPase activity in mammals 
appears mainly to result from increased molecular activity, which represents the maximum 
working capacity of a single Na+-K+-ATPase. By comparing a variety of mammalian and 
ectothermic species, Else et al (1996) have found that the molecular activities of Na+-K+- 
ATPase in mammalian tissues are 6,000-12,000 ATP/min, compared to 1,500-2,500 
ATP/min in tissues from ectotherms. Recently, a hypothesis has been proposed that 
membranes, in particular the fatty acid composition of the membrane phospholipid bilayer, 
may act as a pacemaker of cellular metabolism by regulating the activity of membrane- 
associated proteins (Hulbert & Else 2000). In support of this notion, a reconstitution study 
between mammalian and ectothermic tissues demonstrated that molecular activity of the 
sodium pump was related to the fatty acid composition of the membrane into which the 
sodium pump was incorporated (Else & Wu 1999).
In nervous tissues where many transmembrane ion fluxes occur, the energy consumed to 
maintain transmembrane ion gradients (in which the sodium pump plays a central role) 
accounts for a high percentage (-40%) of the total metabolism (Rolfe & Brown 1997). 
Apart from central nervous tissues where the sodium pump is extensively expressed, the 
sodium pump has been identified in various structures of peripheral nervous tissues (Gill 
1982; Wood et al 1977; Schwartz et al 1981). However, information is lacking on the 
molecular activity of the sodium pump in peripheral nerves, and no comprehensive 
comparison of the sodium pump has been made between the whole nervous systems of 
endotherms and ectotherms.
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The aim of the present study was to determine the molecular activity of the sodium pump 
in both central and peripheral nervous tissues of a mammal (.Rattus norvegicus) and an 
ectotherm (Bufo marinus), and to analyze the membrane fatty acid composition of these 
tissues. The sodium pump molecular activity was compared among the tissues of the two 
species. Existence of correlation between sodium pump molecular activity and various 
parameters of membrane fatty acid composition was explored.
3.2 Results
3.2.1 H-ouabain binding at multiple ouabain concentrations
3H-ouabain binding was determined at multiple ouabain concentrations ranging from 5 x 
10'7 to 5 x 10'5 M (0.5 ~ 50 pM). The results of specific binding were corrected for 
radiopurity of 3H-ouabain (see section 2.1.2) and loss of specific binding during washout 
(table 2.2). Specific binding at different ouabain concentrations was illustrated by binding 
isotherms for different tissues (figure 3.1). Sodium pump concentration, represented by the 
maximum binding in each tissue, was presented in table 3.1 by the result obtained at 5 x 
10’5 M ouabain. A common pattern was observed in most tissues (except rat kidney and 
heart) that specific binding increased curvilinearly with ouabain concentration and then 
approached a plateau level at higher ouabain concentrations. Both rat and toad followed 
the same order of sodium pump concentration, i.e. brain > spinal cord > kidney > sciatic 
nerve > heart (for values see table 3.1), although large variation was observed among 
different tissues. Toad expressed 3~4 time higher sodium pump concentrations in brain, 
spinal cord and kidney than the same tissues from rat (P<0.01). However, the two species 
displayed the same level of sodium pump in sciatic nerve and heart (F>0.05). Two levels 
of plateau phase were observed in rat kidney and heart. This pattern might represent the 
existence of two classes of ouabain-binding sites with different affinities for ouabain, or 
the consequence of interaction between the same class of ouabain-binding site based on 
sodium pump configuration (see section 3.3).
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(a ) Brain
Figure 3.1 Binding isotherms of 3H-ouabain in rat and toad tissues
♦ Rat ■ Toad
(b) Spinal cord
uM
(c) Sciatic nerve (d ) Kidney
(e ) Heart
Specific binding of 3H-ouabain was determined at multiple ouabain concentrations from 0.5-50 pM. Tissue biopsies 
were incubated for 2 hr followed by a washout of 5 x 8 min. Results were corrected for the loss of specific binding during 
washout and radiopurity of 3H-ouabain. Binding isotherms of both rat and toad are displayed in the same plot. A biphasic 
pattern, composed of a curvilinear phase followed by a plateau phase, was observed in most tissues except rat kidney and 
heart where two distinct plateau levels were observed. Sodium pump concentration followed a same order for both 
species: brain > spinal cord > kidney > sciatic nerve > heart. In brain, spinal cord and kidney, sodium pump 
concentrations were 3 - 4  time higher in toad than the same tissues of rat, but the concentrations in sciatic nerve and heart 
were similar for both species. Rat tissues were represented by ♦, while toad tissues by ■. Each point represents the mean 
value of 4-8 determinations (except 0.5 pM, n=l or 2) with SEM as the error bar.
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3.2.2 Na+-K+ -ATPase activity
In vitro Na+-K+-ATPase activity of each tissue, represented by ouabain-inhibited ATP 
breakdown, is shown in table 3.1. Similarly, Na+-K+-ATPase activity also displayed a 
common order for both rat and toad: brain > kidney > spinal cord > heart > sciatic nerve. 
Contrary to the observation for sodium pump concentration, Na+-K+-ATPase activities of 
rat tissues were higher than the same tissue of toad (P<0.01 in all tissues except in heart 
where P<0.05). The difference between the two species varied significantly in different 
tissues, ranging from 139% (brain), to 102% (kidney), to 100% (sciatic nerve), to 88% 
(spinal cord) and to 48% (heart). Comparison of Na+-K+-ATPase activity between rat and 
toad tissues is illustrated in figure 3.2.
Figure 3.2 Comparison of Na+-K+-ATPase activity (at 37°C) between rat and toad tissues
3 -,
Brain Spinal Sciatic Kidney Heart 
cord nerve
Na+-K+-ATPase activity is higher in rat tissue than in the same tissue of toad. The difference varies markedly for 
different tissues, from 48% to 139%. Solid bar represents rat tissues, and empty bar for toad tissues. Values represent the 
means of 6~11 determinations (see table 3.1), with standard error represented by the error bar.
3.2.3 Molecular activity o f the sodium pump
Molecular activity of the sodium pump was calculated from the results of Na+-K+-ATPase 
activity and sodium pump concentration at 5 x 10‘5 M ouabain obtained in the same 
sample. Except for sciatic nerve (at 1,500 ATP/min), rat tissues displayed molecular 
activities at 5,000—10,000 ATP/min. In contrast, apart from heart (at 5,000 ATP/min), toad 
tissues displayed values at 1,000-1,700 ATP/min (see table 3.1). Due to the opposite 
relationship for Na+-K+-ATPase activity and sodium pump concentration, the difference 
between rat and toad increased for brain, spinal cord and kidney in terms of molecular 
activity. For brain, molecular activity of the sodium pump in rat was 6.5 times that of toad. 
The ratio was 5.7 for kidney, and 5.5 for spinal cord. However, comparison of Na+-K+-
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ATPase molecular activities in sciatic nerve and heart revealed that no significant 
difference existed between the two species (P>0.05). Comparison of sodium pump 
molecular activity in rat and toad tissues is illustrated in figure 3.3.
Figure3.3 Comparison of sodium pump molecular activity between rat and toad tissues
Brain Spinal Sciatic Kidney Heart 
cord nerve
In terms of molecular activity of the sodium pump, 5.5-6.5-fold difference was observed between rat and toad in brain, 
spinal cord and kidney, whereas no significant difference was found in sciatic nerve and heart (P>0.05). Solid bar 
represents rat tissues, and empty bar for toad tissues. Values represent the means of 3-4 determinations (see table 3.1), 
with standard error represented by the error bar.
Table 3.1 Molecular activity of the sodium pump in rat and toad tissues
Rat Toad
Sodium pump 
concentration 
(pmol/g T)
Na+-K+-ATPase 
activity
(pmol Pi/mg T»hr')
Molecular
activity
(ATP/min)
Sodium pump 
concentration 
(pmol/g T)
Na+-K+-ATPase 
activity
(|iimol Pi/mg T«hr_1)
Molecular
activity
(ATP/min)
Brain 5826±687
(n=7)
2.65±0.12 
(n=9)
7294±470
(n=4)
18257±843b
(n=6)
1.1 l±0.08b 
(n=6)
1121±58b 
(n=3)
Spinal cord 4164±538
(n=7)
1.62±0.07
(n=9)
6694±476
(n=4)
12662±1521b
(n=6)
0.86±0.05b
(n=6 )
1221±163b
(n=3)
Sciatic nerve 1389±130
(n=7)
0.14±0.01 
(n=l 1)
1566±132
(n=3)
1079±140
(n=6)
0.08±0.01b
(n=8)
12471177
(n=4)
Kidney 3740±408
(n=8)
2.18±0.13 
(n=l 1)
9407±539
(n=5)
12101±1144b 
(n=7)
1.08±0.07b
(n=8 )
1651117 lb 
(n=4)
Heart 1194±203 
(n=6 )
0.37±0.03
(n=8 )
5376±308
(n=4)
8661108
(n=6)
0.25±0.02a
(n=8 )
49151440
(n=3)
Sodium pump concentration values in this table are those obtained at 50 pM ouabain, which presumably represent the maximum specific 
binding in the tissues according to their binding isotherms. Sodium pump concentration was measured as picomoles specific ouabain 
binding per gram tissue, assuming a single ouabain binding site per pump molecule. Na+-K+-ATPase activity was measured as release of 
micromole inorganic phosphate per mg tissue every hour that is inhibited by ouabain. Molecular activity of the sodium pump was 
calculated by dividing the Na+-K+-ATPase activity with the sodium pump concentration determined in the same sample, measured as the 
number of ATP consumed by a single sodium pump molecule per minute. All the values are expressed in form of meanlSEM, with n 
values in the parentheses.a andb represent significant difference between rat and toad tissues at P<0.05 and P<0.01 respectively.
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3.2.4 Membrane fatty acid composition
The fatty acid compositions of the tissue PL extracts are shown in table 3.2 and 
comparisons of fatty acid composition between the rat and toad tissues in figure 3.4.
In brain, the proportion of total MUFAs was similar in both rat and toad, while that of 
PUFAs was higher in toad (PcO.Ol), and thus higher PUFA/MUFA ratio in toad (Pc0.05). 
Rat brain contained more C18:ln-9 (Pc0.05) but less C16:ln-7 (PcO.Ol) than toad brain. 
The contents of n-6 PUFAs were higher in toad brain (PcO.Ol), with the difference mostly 
from C20:4n-6 (PcO.Ol). On the other hand, rat brain contained more n-3 PUFAs 
(PcO.Ol), with the difference mostly contributed C22:6n-3 (PcO.Ol). Consequently, ratio 
of n-6/n-3 was significantly higher in toad brain (PcO.Ol). However, the ratio of C20:4n- 
6/C18:2n-6 was significantly higher in rat brain (PcO.Ol). Overall unsaturation (UI) and 
average chain length were at the same level for both species.
In spinal cord, although the proportions of total unsaturates were similar for both species, 
rat was more monounsaturated (PcO.Ol), which was also manifested by the higher 
proportion of the n-9 fatty acids in rat spinal cord (PcO.Ol). Toad spinal cord, however, 
contained more PUFAs (PcO.Ol). As a result, similar to brain, the ratio of PUFA/MUFA 
was higher in toad spinal cord (PcO.Ol). The higher proportion of MUFAs in rat spinal 
cord mainly came from higher C18:ln-9 and C20:ln-9 (PcO.Ol for both). The two species 
contained similar levels of n-3 PUFAs, but n-6 PUFAs were higher in toad spinal cord 
(PcO.Ol). Although significant difference was present in most n-6 PUFAs, it was most 
evident in C20:4n-6. Like brain, n-6/n-3 ratio was higher in toad spinal cord (PcO.Ol) and 
the ratio of C20:4n-6/C18:2 n-6 was higher in rat (PcO.Ol). UI value was higher in toad 
spinal cord (PcO.Ol), but no difference was found for average chain length.
Similar to brain, the levels of total MUFAs were similar in the sciatic nerve of both species 
along with higher proportion of PUFAs in toad sciatic nerve (PcO.Ol), leading to higher 
PUFA/MUFA ratio in toad (Pc0.05). MUFAs were predominantly C18:ln-9 in both 
species. As observed in brain, rat sciatic nerve contained more n-3 fatty acids (PcO.Ol)
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while toad sciatic nerve contained more n-6 fatty acids (PcO.Ol). Likewise, the n-6/n-3 
ratio was higher in toad sciatic nerve (P<0.01). This resulted from variations in a number 
of n-6 and n-3 fatty acids. Furthermore, higher C20:4n-6/C18:2 n-6 ratio was also present 
in rat sciatic nerve (P<0.01). UI and avCL were at the same level for both species.
When the three nervous tissues were compared. A tendency was noticed that, for both rat 
and toad, membranes became increasingly monounsaturated but decreasingly 
polyunsaturated from brain to spinal cord to sciatic nerve. The ratio of C20:4n-6/C18:2n-6 
decreased from brain to spinal cord to sciatic nerve in both species. Furthermore, UI also 
displayed a tendency to decrease from brain to spinal cord to sciatic nerve in both species.
In kidney and heart, the proportions of PUFAs were at the same level for both species, but 
toad contained more MUFAs resulting from markedly higher level of C18:ln-9 (P<0.01). 
n-6 and n-3 fatty acids were distributed in a similar pattern to that in the nervous tissues, 
although the distribution among individual fatty acids varied significantly. In kidney, an 
interesting pattern was noticed that rat contained markedly higher C20:4n-6 (P<0.01) 
while toad contained markedly higher C18:2n-6 (P<0.01). UI was higher in the kidney and 
heart of rat (P<0.01 and P<0.05 respectively), while avCL values were still similar in both 
species. When they were compared with the three nervous tissues, the common features 
were lower n-6/n-3 ratio and higher C20:4n-6/C18:2n-6 ratio in rat tissues than the 
equivalents of toad (P<0.01 in all cases).
Figure 3.4 Comparison of membrane fatty acid composition between rat and toad tissues
■ Rat □ Toad
(a) Brain
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(b) Spinal cord
(c) Sciatic nerve
Fatty acids
(d) Kidney
(e) Heart
Figure (a)~(e) represent brain, spinal cord, sciatic nerve, kidney and heart respectively, with solid bar for rat and empty 
bar for toad. Each value represents the mean of 3~9 determinations, the error bar for SEM.
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Table 3.2 Membrane fatty acid composition of various tissues from rat and toad
Brain Spinal cord Sciatic nerve Kidney Heart
Rat
(n=6)
Toad
(n=4)
ooII
Cd 
ö,
Toad
(n=3)
Rat
(n=5)
Toad
(n=5)
Rat
(n=6)
Toad
(n=9)
Rat
(n=6)
Toad
(n=5)
C16:0 21.6±0.3 24.611.1 13.410.5 19.510.7b 21.110.3 15.810.3b 18.610.3 15.910.7“ 11.810.3 10.011.6
C17:0 0.610.1 0.310.0b 1.010.2 0.510.2 1.010.4 1.810.5 0.410.0 0.810.2 0.510.0 0.610.2
0 8 : 0 18.110.2 12.311.0b 12.810.3 8.312.7b 8.310.4 10.010.5“ 16.010.4 8.710.4b 20.811.1 11.311.0
C20:0 0.210.0 0.110.0 1.710.1 0.3±0.0b 1.210.1 0.4 i0 .0b 0.210.0 0.210.0 0.210.0 0.3l0.0b
C22:0 0 0 0.210.1 0 0 0 0 0.210.0 0 0
C16:ln-7 1.310.2 4.010.2b 1.310.2 3.610.7b 2.410.3 2.010.3 1.010.1 1.810.3“ 0.510.1 1.010.1“
C17:ln-7 1.110.3 0.810.2 1.710.4 0.910.1 1.910.5 2.110.5 0.410.1 0.510.1 0.610.2 0.410.1
C18:ln-7 4.010.1 4.310.7 7.010.2 5.410.2“ 3.510.2 4.010.1 3.310.2 2.2 i0 .4b 4.010.2 3.910.8
C18:ln-9 20.210.4 18.610.5“ 32.510.5 2 5 .4 il.7 b 42.411.7 43.311.3 9.210.4 19.310.7b 6.111.1 15.710.8b
C20:ln-9 1.310.1 0.710.4 8.610.1 1.410.1b 0.710.1 0.910.1 0.210.0 0.310.0 0.410.2 0.310.1
C20:3n-9 0.210.0 0.110.0 0.110.0 0.310.0“ 0.210.0 0.610.l b 0.210.0 0.210.0 0.110.0 0.210.0
C22:ln-9 0.210.0 0 0.510.0 0.310.1“ 0.210.1 0.210.1 0 0.210.1 0.110.0 0.110.0
C24:ln-9 0.110.0 0 0.110.0 0 0.410.1 0.110.0b 0.310.1 0.110.0“ 0 0.410.0
C18:2n-6 0.610.0 2.010.2b 0.810.0 3.510.4b 1.210.1 7.610.3b 10.510.4 21.312.0b 16.411.0 28.212.0b
C18:3n-6 0 0 0 0 0 0 0.310.1 0.210.1 0.210.1 0.210.1
C20:2n-6 0.210.0 0.610. l b 0.710.0 1.810.4b 0.210.0 1.410.2b 0.410.0 0.710.l b 0.310.0 0.410.1
C20:3n-6 0.310.0 0.510.1 0.610.0 1.610.2b 0.510.0 1.910.1b 0.810.1 0.610.0 0.410.0 0.310.0
C20:4n-6 11.310.2 19.510.3b 4.310.1 14.211.7b 4.310.2 6.510.6b 30.610.5 16.711.3b 21.811.4 18.011.0
C22:4n-6 2.310.1 1.710.1b 1.810.1 1.510.2 1.010.1 0.910.3 0.410.0 0.710.l b 0.910.1 0.510.1
C18:3n-3 0 0.110.0 0.310.0 0.210.1 0 0.310.0 0 0.310.1 0.110.0 0.210.1
C20:3n-3 0.210.0 0 0 0.210.0 0 0 0.710.2 0.310.1 0.410.1 0
C20:5n-3 0.210.0 0.210.0 1.110.1 0.210.0b 2.910.4 0.410. l b 0.610.1 0.710.1 0.310.0 0.510.1
C22:3n-3 0.310.1 1.2i0.1b 0.210.0 1.510.l b 0.110.0 0.310.1“ 0.210.0 0.310.1 0.910.1 0.710.2
C22:5n-3 0.310.1 0.410.2 1.310.2 0.410.0“ 2.610.4 0.610.2b 1.410.1 1.010.1 1.410.3 1.410.2
C22:6n-3 16.110.4 8.910. l b 8.110.2 9.510.9 4.310.1 1.910.2b 4.810.1 2.010. l b 12.410.4 6.110.4b
MUFA 27.910.4 27.011.7 51.710.6 36.912.5b 51.311.0 49.811.4 14.210.3 23.711. l b 11.611.7 21.311.3b
PUFA 31.510.4 35 .U 0.6b 19.110.5 34.410.7b 17.110.6 22.3l0.9b 50.610.8 50.810.8 55.111.1 56.411.3
n-3 16.910.4 10.610. l b 10.910.4 11.511.3 9.810.6 3.410. l b 7.610.2 4.610.3b 15.110.4 8.710.5b
n-6 14.610.2 24.410.6b 8.210.2 22.612. l b 7.210.3 18.311.0b 42.810.8 46.011.1 39.910.9 47.511.6b
n-9 21.610.4 19.510.5“ 41.710.6 27.311.5b 43.511.7 44.911.1 9.710.3 19.810.7b 6.511.5 16.210.8b
n-7 6.410.3 7.611.7 10.010.8 9.910.9 7.910.8 5.510.6 4.710.2 4.110.5 5.110.3 5.311.0
PU/MU 1.110.0 1.310.1“ 0.410.0 0.9±0.0b 0.310.0 0.410.0“ 3.610.1 2.210. l b 5.110.6 2.710.l b
n-6/n-3 0.910.0 2.310. l b 0.810.0 2.010.2b 0.710.1 5.410.5b 5.710.2 10.610.9b 2.610.1 5.610.5b
20:4/18:2 19.210.7 9 .811.2b 5.810.3 4.010. l b 3.610.3 0.910.l b 2.910.1 0.710. l b 1.410.2 0.710.l b
avCL 18.610.0 18.310.0 18.510.0 18.410.0 18.010.1 18.010.0 18.610.0 18.210.0 18.810.0 18.510.1
UI 184.511.8 178.412.7 142.912.3 179.711.8b 130.311.9 122.710.9 204.712.3 174.912.4b 223.214.0 :202.414.3“
Proportions of individual fatty acids are expressed area percentage of total identified fatty acids.“ andb represent significant difference 
between rat and toad tissues at P<0.05 and PcO.Ol respectively.
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3.2.5 Relationship between sodium pump molecular activity and membrane fatty acid 
composition
Regressional analysis was performed between sodium pump molecular activity and a 
number of parameters of membrane fatty acid composition. However, among unsaturation 
index, percentages of MUFAs and PUFAs, ratios of PUFA/MUFA, n-6/n-3 and C20:4n- 
6/C18:2n-6, and percentage of C22:6n-3, none was found to be significantly correlated to 
sodium pump molecular activity (P>0.05). Pearson’s coefficient and P value of each 
examination are shown in figure 3.5.
Figure 3.5 Relationship between sodium pump molecular activity and 
membrane fatty acid composition in rat and toad tissues
50 100 150 200
Unsaturation index
250
♦ Rat brain O Toad brain
■ Rat spinal cord □ Toad spinal cord 
▲ Rat sciatic nerve A Toad sciatic nerve
*  Rat kidney X Toad kidney
-  Rat heart +  Toad heart
2 4
PUFA/MUFA
10 20 30 40
MUFAs (%)
50 60
10000 
8000 
6000 - 
4000 - 
2000 
0
r=0.285
P=0.424
0 20 40
PUFAs (%)
60
0
38
0 2 4 6 8 10 12
n-6/n-3
100003
|  8000 
H 
<
X, 6000 
>
1 4000S
u 2000 
os 0
0 5 10 15 20 25
C20:4n-6/C 18:2n-6
Regression analysis was performed between sodium pump molecular activity and a number of parameters of membrane 
fatty acid composition, including UI, percentages of MUFAs and PUFAs, ratios of PUFA/MUFA, n-6/n-3 and C20:4n- 
6/C18:2n-6, and percentage of C22:6n-3. Means of sodium pump molecular activity in all the tissues were plotted against 
means of these parameters in the same tissues. Pearson’s r value and P value were calculated (as shown in the graphs). 
No significant correlation was found between sodium pump molecular activity and any of the parameters of membrane 
fatty acid composition.
3.3 Discussion
In the present study, molecular activity of the sodium pump and membrane fatty acid 
composition were investigated in three nervous tissues and two non-nervous tissues of rat 
and toad. Molecular activity of the sodium pump was 5,000-10,000 ATP/min in rat tissues 
(with the exception of sciatic nerve at -1,600 ATP/min), but 1,000-1,700 ATP/min in toad 
tissues (with the exception of heart at -5,000 ATP/min). The sodium pump molecular 
activities in rat brain, spinal cord and kidney were 5.5-6.5 times those in the same tissues 
of toad. However, no significant difference was found in sciatic nerve and heart between 
the two species (P>0.05), although the values in heart were much higher than in sciatic 
nerve. Comparison of membrane fatty acid compositions of these tissues showed that toad 
tissues contained more n-6 PUFAs while the same tissues of rat contained more n-3 
PUFAs. Among the nervous tissues, monounsaturation increased while polyunsaturation 
decreased from brain to spinal cord to sciatic nerve, along with a decrease of overall 
unsaturation (UI). However, no significant correlation was detected between the sodium 
pump molecular activity and a number of parameters of membrane fatty acid composition.
In the nervous system, a large number of neurological processes and functions are 
dependent on the activity of the sodium pump, such as maintenance and recovery of ion
gradients, uptake and excretion of neurotransmitters (Tissare et al 1969). For example, in 
diabetic neuropathy, a decrease in nerve conduction velocity has been associated with 
decreased Na+-K+-ATPase activity (Gerbi et al 1999; Yorek et al 1996). Three isoforms of 
the a  subunit have been cloned in rat, a i, a 2 and 0C3, with different ouabain affinity and 
tissue expression, oq isoform has low ouabain affinity (Kd at 1-50 pM) while a 2 and 013 
have high affinity ( K d  at 0.01-0.5 pM) (Fambrough et al 1994). In the nervous system, all 
three isoforms have been identified with specific distribution. Northern blotting has found 
universal expression of a i in brain, but a 2 only in glia, and 0C3 predominantly in neurons 
(Watts et al 1991). Similarly, immunostaining has detected universal distribution of oq in 
spinal cord, while a3 concentrated in motor neurons (Dolapchieva 1998). This specific 
distribution also exists in peripheral nerves. In sciatic nerve, a i is ubiquitously expressed 
as the predominant isoform, while a 2 exclusively in Schwann cells and (X3 in axons (Kawai 
et al 1997). For toad sodium pump, however, information is limited regarding 
polymorphism and binding properties, although some evidence suggests the possibility of 
multiple Na+-K+-ATPase isoforms (Morris et al 1997).
In the present study, only one saturation level was observed in the binding isotherms of 
most of the tissues (except rat kidney and heart), suggesting one single ouabain-binding 
site. Kd values estimated from the isotherms of both species vary between 3~40 pM in 
different tissues (see appendix II), well within the range of affinity of oq isoform. In rat 
kidney and heart, KD values for both saturation levels fall in the range of the low-affinity 
OCi isoform. Therefore, rather than two different binding sites, the two saturation levels are 
more likely to be the result of interaction between the same binding sites or subunit­
subunit interaction in multimeric proteins. Actually, a dimeric structure has been proposed 
as a functioning form of sodium pump (Linnertz et al 1998). The ouabain concentration 
range used in this study is probably the reason that no other sodium pump isoforms were 
characterized. At the ouabain concentrations of 0.5-50 pM, the predominant low-affinity 
site would have overshadowed any high-affinity sites in the tissues. Lower ouabain 
concentrations are needed to characterize the high-affinity sites. A high-affinity binding 
site (Kd at 0.05 pM) has been identified in sciatic nerve in another study (Kjeldsen
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&N0rgaard 1987) using 0.01-5 pM ouabain. However, the total number of sodium pump 
would not be affected as both low- and high-affinity sites were occupied at high ouabain 
concentration.
The 3-4-fold variation in sodium pump concentration between rat and toad tissues agrees 
with other studies using the same method (Else et al 1996; Windmill 1993; Markus 1991). 
The result for rat brain is similar to that of Else et al (1996), but the result for toad brain in 
the present study is much higher (about 80%) although the same range of ouabain 
concentration was used. However, in another study by Windmill (1993), the sodium pump 
concentration at 50 pM ouabain was 14,700 pmol/g, which is closer to that obtained in the 
present study. In kidney, the result of present study is similar to that of Else et al (1996) for 
toad but only about half as much for rat. This difference appears to result from the choice 
of tissue, i.e., rat kidney cortex was used in the present study instead of whole kidney. It 
has been observed that concentration of sodium pump varies in different segments of 
nephron, especially densely packed in the thick ascending limb of Henle loop and distal 
convoluted tubules which are mainly located in outer medulla (Jorgensen 1986). In a study 
by Markus (1991) where the concentration of sodium pump was determined in both cortex 
and outer medulla of rat kidney, the outer medulla was found to contain much higher 
concentration of sodium pump than the cortex (7,500 vs. 3,250 pmol/g). The results for 
heart in this study are similar to those of Else et al (1996) for both rat and toad.
Information on sodium pump concentration in spinal cord and sciatic nerve of rat and toad 
is limited in literature. In a study on rat sciatic nerve (Kjeldsen & Norgaard 1987) using 
vanadate-facilitated 3H-ouabain binding at ouabain concentration of 0.01-5 pM, the 
concentration of sodium pump obtained was 145-172 pmol/g tissue, about one tenth of the 
concentration in the present study. As discussed above, this low concentration range is 
lower than required to saturate the low-affinity isoform, so the result does not represent the 
real sodium pump concentration as the maximum binding was not achieved. Because a 
different method was used (vanadate facilitates ouabain binding by acting as a phosphate 
analogue and changing the equilibrium between conformations), the results of the present
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study at 0.5-1 jliM  are lower than those of Kjeldsen & Norgaard (1987), 9~25 vs. 120-150 
pmol/g.
In the present study, all rat tissues displayed higher Na+-K+-ATPase activity (1.48-2.39 
times) compared to the same tissues of toad. This is consistent with observations in 
previous studies (Else et al 1996; refer to sections 1.1.2 and 3.1). The Na+-K+-ATPase 
activities in kidney, brain, sciatic nerve and heart are similar to the known data (Else et al 
1996; Greene et al 1984; Windmill 1993; Markus 1991). Variation in Na+-K+-ATPase 
activity could result from any of a variety of physiological, phylogenic or experimental 
factors such as body size, sex, source of animals, homogenization, incubation temperature 
and time. It should be noted that the Na+-K+-ATPase activity was measured at a 
temperature (37°C) higher than the natural temperature for toad. Therefore, the results of 
Na+-K+-ATPase activity in toad tissues have overestimated the enzyme capacity normally 
achieved (the Na+-K+-ATPase activities at 25°C and 37°C, and Qio value for each tissue 
are presented in appendix I).
Except for sciatic nerve and heart, molecular activity of the sodium pump was 5.5-6.5 
times higher in rat tissues than in toad tissues. This is in conformity with the observation of 
Else et al (1996) that the difference in molecular activity accounts for the difference in 
Na+-K+-ATPase activity between endotherms and ectotherms. However, the sodium pump 
molecular activity in rat sciatic nerve is only about a fifth of that in brain and spinal cord 
(1,600 ATP/min), at the same level as toad sciatic nerve (P>0.05). On the other hand, high 
sodium pump molecular activity in toad heart was found in this study (4,900 ATP/min) 
similar to that in rat heart (P>0.05). This exception in toad heart was also noticed in the 
study of Else et al (1996). Actually, high sodium pump molecular activity has been 
reported in a number of ectothermic tissues, such as frog brain (Bader et al 1968). The 
molecular basis for this exception is still not clear.
Causes of the variation in sodium pump molecular activity have been extensively 
discussed in previous studies (Else et al 1996; Else & Wu 1999). One explanation is that 
different isoforms in various tissues and species have different molecular activities.
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Although alignment of sodium pump protein sequences from various vertebrates revealed a 
high degree of homology (85-90%) for both a  and (3 subunits (Fambrough 1988;
Sweadner 1989), it is still possible that the remaining differences in amino acid sequence 
produce variations in molecular activity. However, it is noted that the same isoform of the 
sodium pump, 04, prevails in both rat kidney and sciatic nerve, but a 6-fold variation in 
molecular activity was found between the two tissues. This suggests different isoforms are 
unlikely, at least in this case, to be the reason for the variation in sodium pump molecular 
activity. Isoform-specific study of molecular activity is needed before this issue can be 
resolved. Alternatively, another explanation has been proposed recently that differences in 
membrane fatty acid composition leads to differences in molecular activity of the sodium 
pump (Hulbert & Else 2000; Else & Wu 1999). It is hypothesized that membranes act as a 
pacemaker of cellular metabolism by regulating the activities of membrane-associated 
proteins (see section 1.1.3 and 1.1.4). In order to examine its validity in these tissues, 
membrane fatty acid composition was determined in the present study.
It should be noted that the tissue preparation used for analysis of fatty acid composition 
was phospholipid extract, which is the predominant component of membrane structure. 
However, instead of solely plasma membrane with which Na+-K+-ATPase is associated, 
this preparation also contains the membranes from mitochondria, endoplasmic reticulum 
and nuclear envelope. In a previous study on brain and kidney of rat and toad, microsomal 
factions were used instead of total tissue phospholipids (Else & Wu 1999, results shown in 
table 3.3). For kidney, strikingly similar profiles were obtained for both rat and toad 
between the present study and the study of Else & Wu (1999), suggesting that the 
influence on fatty acid composition of other membranes is, at least in kidney, minor. 
However, compared to the results from Else & Wu (1999), rat brain in the present study 
was more monounsaturated (especially in C18:ln-9, 20.2% vs. 15.5%) but less 
polyunsaturated (most evident in C22:6n-3, 16.1% vs. 19.7%), resulting in lower values for 
the ratio of PUFA/MUFA (1.1 vs. 1.7) and UI (184.5 vs. 207). Apart from contribution of 
other membrane components, the lower UI and PUFA/MUFA also result from myelin, 
which is highly monounsaturated (Palestini et al 1993). Similarly, compared to the results 
of Else & Wu (1999), toad brain of the present study showed contained higher proportion
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of MUFAs (18.6% vs. 16.9% for C18:ln-9) and less long-chain PUFAs (8.9% vs. 11.5% 
for C22:6n-3). Consequently, lower PUFA/MUFA (1.3 vs. 1.6) and UI (178 vs. 186) were 
observed. Although no definite evidence is available regarding myelination in toad brain, 
myelin sheath has been identified in other parts of the nervous system of toad (Mateu et al 
1997; Del Grande et al 1985). These results suggest that purification of microsomes has 
reduced the influence from myelin in brain for both rat and toad. The fatty acid 
composition of rat brain in this study is almost identical to the results of another study 
using phospholipid extract of rat (Zucker) brain (Guesnet et al 1990). However, another 
study on rat (Wistar) brain using tissue phospholipid extract (Couture & Hulbert 1995a) 
obtained a higher UI value than the present study (228 vs. 184.5), suggesting that, for 
brain, variation might exist among different strains of rat in terms of membrane fatty acid 
composition, or more likely, the degree of myelination. Another reason could be the age of 
rat used in different studies, as it has been found that membrane fatty acid composition 
varies in different development stages in rat (Jumpsen et al 1991; Wu 2000). 
Unfortunately, no comparison could be made because the age of rat was not provided in 
the study of Couture & Hulbert (1995a).
Compared to the fatty acid composition of microsomal PL of heart (Wu 2000, as shown in 
table 3.3), the fatty acid composition results of the present study displayed higher 
percentages in C20:4n-6 (21.8% vs. 13.8% for rat and 18.0% vs. 15.0% for toad) and 
C22:6n-3 (12.4% vs. 8.9% for rat and 6.1% vs. 3.8% for toad). The proportion of n-6 fatty 
acids in the present study was higher for both rat and toad (39.9% vs. 35.3% and 47.5% vs. 
44.3% respectively) while the content of n-3 fatty acids was higher in microsomal PL of 
rat heart (18.5% vs. 15.1%) but lower in microsoaml PL of toad heart (6.6% vs. 8.7%). 
Higher UIs were obtained in the tissue PL extracts of the present study, 223.2 vs. 215.6 for 
rat heart and 202.4 vs. 180.2 for toad heart respectively. This is contrary to the data of 
Brookes et al (1997) where the fatty acid composition of the mitochondrial inner 
membrane is more saturated with lower UI than total phospholipids of the same tissue, 
which would result in higher UI values in microsomal fraction than in total PL. Little 
information is available about the fatty acid composition of spinal cord and sciatic nerve. 
Large variations are observed between the profile of sciatic nerve in this study and that
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from another study on Zucker rat (Guesnet et al 1990). It should be noted that the 
contribution of myelin is important because of its high content in these two tissues.
Table 3.3 PL fatty acid composition of the microsomal fractions of kidney, brain 
and heart of rat and toad from Else & Wu (1999) and Wu (2000)
Fatty acid Kidney Brain Heart*
Rat
(n=6)
Toad
(n=6)
Rat 
(n= 6)
Toad
(n=5)
Rat
(n=3)
Toad
(n=4)
C16:0 16.8±0.6 17.110.1 20.810.9 23.710.9a 10.610.7 12.710.4a
C18:0 16.8±0.7 8.9210.17b 18.110.5 16.010.2a 22.910.7 12.910.5”
C16:ln-7 0.43±0.04 1.71i0.04b 0.3410.07 2.0710.23” 0.310.0 0.710.0”
C18:ln-7 2.68±0.37 1.7210.1 lb 4.8610.60 3.0210.15a 2.610.1 4.010.4”
C18:ln-9 9.47±0.36 19.010. lb 15.510.3 16.910.4s 7.010.2 16.910.5”
C18:2n-6 8.43±0.59 27.810.3b 0.6110.06 1.6710.05” 17.210.6 27.910.9”
C20:4n-6 33.6±0.48 15.510.1 lb 11.910.4 16.910.4” 13.810.2 15.010.2”
C22:4n-6 - - 2.8710.21 2.0410.07a 1.010.0 0.510.0”
C20:3n-3 2.3710.87 0.3210.06s - - 0.410.0 0.410.2
C22:5n-3 - - 0.6210.06 1.6410.08” 4.310.1 1.710.1”
C22:6n-3 2.8710.05 0.9010.02b 19.710.4 11.510.1” 8.910.1 3.810.1”
MUFA 13.710.7 23.610. lb 22.211.0 22.910.5 11.610.5 22.210.1”
%Unsaturates 65.111.1 73.010.2b 59.911.3 58.810.9 65.611.5 73.611.0a
n-3 6.7310.64 3.5110.08b 20.1910.52 12.510.1” 18.510.3 6.610.1”
n-6 43.410.2 45.110.2b 16.210.29 22.710.5” 35.310.9 44.310.9”
n-9 10.110.3 20.410.2b 15.910.4 17.910.4a 7.410.2 17.510.5”
n-7 3.9810.50 3.9610.10 6.410.7 5.6410.25 4.410.3 5.110.3
n-6/n-3 6.7810.69 12.910.3” 0.8010.03 1.8210.04” 1.910.1 6.710.2”
avCL 18.410.1 18.110.0 18.510.0 18.410.0 18.710.0 18.310.0”
UI 20213 16611” 20713 18713” 215.613.4 180.212.1”
a and b represent difference between rat and toad at P<0.05 and P<0.01 respectively. *, data of 
heart are from Wu (2000).
As discussed before, Na+-K+-ATPase activity has been found to be positively correlated 
with C22:6n-3 content and unsaturation index (Gerbi et al 1994; Corrocher et al 1990). As 
far as sodium pump molecular activity is concerned, positive correlation has been 
identified with UI and content of long-chain PUFAs (P<0.01), while negative correlation
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has been found with n-6/n-3 ratio and content of MUFA (P<0.01) in a study on brain and 
kidney of rat and toad (Wu 2000). However, in the present study, no significant correlation 
has been identified between sodium pump molecular activity and a variety of parameters of 
membrane fatty acid composition (P>0.05) (see figure 3.5). Two possibilities exist that 
could result in the lack of correlation between sodium pump molecular activity and 
membrane fatty acid composition in the tissues examined in the present study. First, it is 
possible that the correlation found in brain and kidney of rat and toad could not be 
expanded to the tissues examined in the present study. However, when the results of brain 
and kidney from the present study were examined, still, none of the parameters of 
membrane fatty acid composition could be significantly correlated to sodium pump 
molecular activity (P>0.05), although the linearity between molecular activity and UI 
increases markedly (r=0.883, P=0.117). Therefore, it seems unlikely that the first 
possibility accounts for the discrepancy. Alternatively, as discussed above, the tissue 
phospholipid extract used in this study contains membranes from multiple sources. As a 
result, the profiles of fatty acid composition may not accurately reflect the composition of 
the immediate environment of Na+-K+-ATPase, i.e. plasma membrane, because of the 
heterogeneity of cellular membrane system (Hoch 1988; Murray et al 1999). Potential 
correlation might have been masked by the interference from other membrane components 
and from myelination in nervous tissues. Therefore, further purification is needed before a 
conclusion could be drawn regarding the relationship between sodium pump molecular 
activity and membrane fatty acid composition.
In summary, the results of the present study produced no evidence suggesting membrane 
(represented by total tissue PL) fatty acid composition regulates sodium pump molecular 
activity. The apparent lack of correlation may result from the heterogeneous composition 
of total tissue PL. In addition, studies have found that other parameters of membrane also 
influence molecular activity of the sodium pump, e.g. cholesterol (CL) content, PL class 
composition and CL/PL ratio (Cornelius 1995; Wu 2000). It would be of interest to 
examine these parameters of membrane in these tissues in future studies.
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Chapter 4 Influence of thyroid status on molecular activity of 
the sodium pump and membrane fatty acid composition
4.1 Introduction
As a part of cellular metabolism, the sodium pump is subject to the regulation of thyroid 
hormones (see section 1.2.4). Thyroid hormones stimulate both sodium pump activity 
(measured as Rb+ uptake by living cells) and Na+-K+-ATPase activity (Ismail-Beigi & 
Edelman 1970; Haber & Loeb 1986). It has been found that thyroid hormones increase 
sodium pump concentration by selectively inducing the isoform with high affinity for 
ouabain (Ewart & Klip 1995). However, his induction appears to be a secondary response 
to increased Na+ and K+ permeability rather than a primary nucleus-mediated response 
(Haber et al 1988). On the other hand, thyroid hormones modify the properties of 
membranes (e.g., fluidity) by changing their composition, e.g. hyperthyroidism increases 
C20:4n-6/C18:2n-6 ratio while hypothyroidism decreases it (Hoch et al 1981; Brand et al 
1992). In contrast to most tissues, thyroid hormones fail to increase sodium pump 
concentration in brain, and, furthermore, do not produce changes in membrane fatty acid 
composition in brain (Lin & Akera 1978; Tacconi et al 1991). This has been linked to the 
characteristic homeostatic system of deiodinases in brain, which function to maintain 
constant local level of T3 as discussed in section 1.2.1 (Hulbert 2000). Although no 
evidence is available suggesting a similar homeostatic deiodinase system in peripheral 
nerves, sciatic nerve displayed similar resistance to change in thyroid status in terms of 
sodium pump concentration (Kjeldsen & Npgaard 1987). However, no study has been 
done regarding the effect of thyroid hormones on sodium pump molecular activity.
This study aims to examine the influence of thyroid status on molecular activity of the 
sodium pump and membrane fatty acid composition in a number of tissues, including 
brain, spinal cord, sciatic nerve, kidney and heart. Sodium pump molecular activity and 
membrane fatty acid composition were determined in laboratory rats (Rattus norvegicus) 
of different thyroid statuses. Existence of correlation was explored between thyroid status, 
sodium pump molecular activity and membrane fatty acid composition in these tissues.
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4.2 Results
4.2.1 Plasma hormone concentrations
The total plasma concentrations of T3 and T4 were determined by RIA in the hyper-, eu- 
and hypothyroid groups (the standard curves of T3 and T4 are shown in figure 4.1). Both T3 
and T4 concentrations in the hyper- and hypothyroid groups were significantly different 
from those in the euthyroid group (P<0.05 and P<0.01 respectively, as shown in table 4.1). 
These results suggest that different thyroid statuses have been achieved in this study.
Figure 4.1 Standard curves of T3 and T4 for RIA
The standard curves of T3 and T4 were displayed in semi-log plot. The 125I activities of standards were converted to 
percentage of the 125I activity of the zero-standard, i.e. B/B0 (%). Standard curves were obtained by plotting the B/B0 (%) 
values of standards against their respective hormone concentrations. Hormone concentrations in plasma samples were 
determined from the standard curves by their B/B0 (%) values.
Table 4.1 Total plasma concentrations of thyroid hormones in different thyroid statuses
H y p e rth y ro id E u th y ro id H y p o th y ro id
(n = 7 ) (n= 6) (n = 7 )
T 3 (n m o l/L ) 1.59 ±  0 .0 9 a,f 1.13 ±  0 .13 0 .6 9  ±  0 .0 7 c,f
T 4 (n m o l/L ) 47 .41  ±  3 .4 6 b,f 3 0 .3 9  ± 2 .6 1 11.41 ± 1 .93d,f
Statistical significance at P<0.05 and P<0.01are represented by a andb (between the hyper- and euthyroid 
groups),c andd (between the hypo- and euthyroid groups),e andf (between the hyper- and hypothyroid 
groups) respectively.
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4.2.2 Effect o f thyroid status on growth
The rats weighed 221.2±5.3g (n=20) upon arrival at the age of 8 weeks. A 2-week 
orientation was allowed before they were randomly consigned to three study groups. Body 
masses of the study groups at the beginning of the study were: hyperthyroid (248.3±8.6g, 
n=7), euthyroid (244.7±5.5g, n=6) and hypothyroid (239.7±6.2g, n=7) respectively. No 
significant difference in body mass was present between the three groups (P>0.05). At the 
completion of the study, body masses of the three study groups were: hyperthyroid 
(272.5±8.7g), euthyroid (264.5±10.1g) and hypothyroid (254.3±7.3g) respectively. Still, no 
significant difference was found between the three groups (P>0.05). Figure 4.2 shows the 
growth of each group from arrival to the time of completion. Brain, spinal cord, sciatic 
nerve, kidney and heart were weighed upon sacrifice. Tissue mass of kidneys (both sides) 
was significantly higher in the hyperthyroid (P<0.05) and significantly lower in the 
hypothyroid group (P<0.05). Tissue mass of heart was significantly higher in the 
hyperthyroid group than the euthyroid (P<0.05) and the hypothyroid group (P<0.01), 
although no difference was observed between the latter two groups. No significant 
difference was identified in the tissue masses of brain, spinal cord and sciatic nerve 
between the three groups (P>0.05) (for values see table 4.2).
Figure 4.2 Influence of thyroid status on growth of body mass
♦ hyperthyroid
-----■  — Euthyroid
- - ■Ar - ‘ hypothyroid
Changes in body mass are shown from the time of arrival (age=8 wks) to the completion of the study (age=12 wks). The 
hyperthyroid group (n=7) is represented by ♦, euthyroid (n=6 ) by ■, and hypothyroid (n=7) by a. Each value represents 
the mean value of the group with the error bar for SEM. No significant difference has been found in body mass either at 
the beginning or the completion of the study.
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Table 4.2 Tissue mass in different thyroid statuses
T h y ro id
s ta tu s
T is su e  m ass  (g)
B ra in S p in a l c o rd S c ia tic  n e rv e K id n ey s H ea rt
H y p e r th y ro id  (n = 7 ) 1 .94± 0 .05 0 .6 1 ± 0 .0 1 O .lliO .O O 1 .9 2 ± 0 .0 6 a’f 1 .0 2 ± 0 .0 5 a,f
E u th y ro id  (n = 6 ) 1 .9 2± 0 .03 0 .5 8 ± 0 .0 1 0 .1 1 ± 0 .0 0 1 .7 2± 0 .05 0 .8 8 ± 0 .0 3
H y p o th y ro id  (n = 7 ) 1 .8 9 ± 0 .0 6 0 .5 8 ± 0 .0 1 0 .1 1 ± 0 .0 1 1 .4 8 ± 0 .0 5 c,f 0 .7 7 ± 0 .0 3
Statistical significance at P<0.05 and P<0.01 are represented by a andb (between the hyper- and euthyroid groups),c andd (between the 
hypo- and euthyroid groups),e and f (between the hyper- and hypothyroid groups) respectively.
4.2.3 Sodium pump concentration in different thyroid statuses 
Sodium pump concentration was determined at 3xl0~5 M ouabain. Sodium pump 
concentration increased significantly in the hyperthyroid group in kidney (37%) and heart 
(61%) (P<0.01 for both) and decreased significantly in the hypothyroid group in kidney 
(42%, P<0.01) and heart (46%, P<0.05). The differences are percentages of the 
concentrations in the euthyroid group. However, no significantly differences were found 
between different thyroid statuses in brain, spinal cord and sciatic nerve (P>0.05). 
Comparisons of sodium pump concentration between different thyroid statuses are shown 
in figure 4.3 (for values see table 4.3).
Figure 4.3 Sodium pump concentration in different thyroid statuses
6000 -,
4500 -
9 3000 -
1500 -
Brain Spinal cord Sciatic Kidney Heart 
nerve
■ Hyperthyroid 
« Euthyroid 
□ Hypothyroid
Sodium pump concentrations in hyper- (n=7), eu- (n=6 ) and hypothyroid (n-7) groups, error bars for SEM. Significant 
difference from the euthyroid group is marked by the star (*) on top of the bar.
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Table 4.3 Molecular activity of the sodium pump in different thyroid statuses
Hyperthyroid (n=7) Euthyroid (n=6) Hypothyroid (n=7)
Sodium pump 
concentration 
(pmol/g T)
Na+-K+-ATPase
activity
(pmol Pi/mg T^hr"1)
Molecular
activity
(ATP/min)
Sodium pump Na+-K+-ATPase 
concentration activity 
(pmol/g T) (prnol Pi/mg T•hr'1)
Molecular
activity
(ATP/min)
Sodium pump 
concentration 
(pmol/g T)
Na+-K+-ATPase
activity
(pmol Pi/mg T -h r1)
Molecular
activity
(ATP/min)
Brain 47821484 6.9110.67 2594213452 44601263 6.9510.42 2656412447 39151350 7.0110.28 3164013587
Spinal cord 48011516 4.5710.46 1737312726 44601647 5.3510.49 2147012351 45321227 4.4710.40 1698712207
Sciatic nerve 11551204 0.3610.03 631111127 8371111 0.3210.02 703711197 752197 0.3010.03 762511342
Kidney 41171156b,f 6.1910.2 lbf 2539511669 29971156 4.9010.23 2747311381 17491246d,f 4.1110.22e 3912913398c,f
Heart 1667il28b,f 1.0210.07bf 1080611364 10351143 0.6310.09 1094111874 5551104c,f 0.5010.07 1611811864
The pump concentration values in this table were determined at 3xl0"5 M ouabain, which presumably represent the maximum specific binding according to the binding isotherms 
while keep the largest difference in ouabain concentration from non-specific binding. Molecular activity of the sodium pump was calculated by dividing the Na+-K+-ATPase 
activity with the sodium pump concentration determined in the same sample. All the values are expressed in form of mean±SEM, with n values in the parentheses.
Statistical significance at P<0.05 and PcO.Olare represented by a and b (between the hyper- and euthyroid groups),c and d (between the hypo- and euthyroid groups),e and f 
(between the hyper- and hypothyroid groups) respectively.
4.2.4 Na+-Kf -ATPase activity in different thyroid statuses
Compared to the euthyroid group, Na+-K+-ATPase activity increased significantly in the 
hyperthyroid group in kidney (26%, P<0.01) and heart (62%, P<0.01). On the other hand, 
Na+-K+-ATPase activity was significantly lower in the hypothyroid group in kidney (16%, 
P<0.05). Similar to that observed for sodium pump concentration, changes in thyroid 
status did not produce significant difference in Na+-K+-ATPase activity in brain, spinal 
cord and sciatic nerve (P>0.05). It was also noticed that hypothyroidism did not change 
Na+-K+-ATPase activity in heart (P>0.05). Comparisons of Na+-K+-ATPase activity in 
different thyroid statuses are shown in figure 4.4 (for values see table 4.3).
Figure 4.4 Na+-K+-ATPase activity in different thyroid statuses
cord nerve
Na+-K+-ATPase activities in hyper- (n=7), eu- (n=6 ) and hypothyroid (n=7) groups, error bars for SEM. Significant 
difference from the euthyroid group was marked by the star (*) on top of the bar.
4.2.5 Molecular activity o f the sodium pump in different thyroid statuses 
Because brain, spinal cord and sciatic nerve were unresponsive to changes in thyroid status 
regarding both sodium pump concentration and Na+-K+-ATPase activity, molecular 
activity of the sodium pump also kept constant in these tissues in different thyroid statuses 
(P>0.05). In the case of kidney and heart, because of the parallel responses of sodium 
pump concentration and Na+-K+-ATPase activity to changes in thyroid status, molecular 
activity of the sodium pump did not change significantly (P>0.05) along with thyroid 
status, except in kidney of the hypothyroid group where the molecular activity increased 
by 42% (P<0.05) from that of the euthyroid group. Comparisons of molecular activity of 
the sodium pump in different thyroid statuses are shown in figure 4.5 (for values see table 
4.3).
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Figure 4.5 Molecular activity of the sodium pump in different thyroid statuses
50000 - 
40000 -
.£ 30000 -E
CL
<  20000 - 
10000 
0
Brain Spinal cord Sciatic Kidney Heart 
nerve
Molecular activities of the sodium pump in hyper- (n=7), eu- (n=6 ) and hypothyroid (n=7) groups, error bars for SEM. 
Significant difference from the euthyroid group was marked by the star (*) on top of the bar.
4.2.6 Membrane fatty acid composition in different thyroid statuses 
By and large, the changes induced in fatty acid composition of tissue phospholipid (PL) by 
different thyroid statuses were small and diverse (see table 4.4). In brain, no significant 
changes in fatty acids were found except a small escalation in C18:2n-6 (P<0.01) along 
with a decrease in PUFA content (P<0.05) in the hypothyroid group. The ratio of C20:4n- 
6/C18:2n-6 significantly decreased in the hypothyroid group (P<0.01). The contents of 
C20:4n-6 and n-6 fatty acids were significantly different between the hyper- and the 
hypothyroid groups (P<0.05). In spinal cord the effect of thyroid status was even less 
remarkable. The only significant changes were increases in C20:3n-6 and C22:4n-6 in the 
hyperthyroid group (P<0.01), while none of the parameters of fatty acid composition were 
changed with thyroid status. In sciatic nerve, hyperthyroidism produced a small increase in 
the content of C20:5n-3 (P<0.05) and the proportion of MUFAs (P<0.05). Similar to brain, 
the ratio of C20:4n-6/C18:2n-6 in sciatic nerve was lower in the hypothyroid group when 
compared to the hyperthyroid group (P<0.05). In summary, all the three nervous tissues 
were rather resistant to changes in thyroid status in terms of membrane fatty acid 
composition. Generally, hypothyroidism displayed a tendency to decrease the ratio of 
C20:4n-6/C 18:2n-6 while hyperthyroidism increased it (although no significant changes 
were identified in spinal cord, this trend was still present). However, no substantial 
changes were consistently induced in the major classes of fatty acids and in overall 
unsaturation (UI) by changes in thyroid status.
■ Hyperthyroid 
a  Euthyroid 
□ Hypothyroid
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In kidney, a decrease was observed in C17:ln-7 (PcO.Ol), C18:ln-9 (Pc0.05) and C18:2n- 
6 (PcO.Ol) in the hyperthyroid group along with a small increase in C22:4n-6 (P<0.01). 
Hyperthyroidism decreased the proportion of MUFAs (P<0.01) and n-9 fatty acids 
(P<0.05) while increased the ratio of PUFA/MUFA (PcO.Ol) and C20:4n-6/C18:2n-6 
(P<0.01). On the other hand, hypothyroidism produced increases in C18:2n-6 (PcO.Ol) 
and C20:5n-3 (PcO.Ol) and a decrease in C18:ln-7 (Pc0.05). A reduction in C20:4n- 
6/C18:2n-6 ratio was observed in the hypothyroid group. Furthermore, significant 
difference was identified in C16:0 and C20:4n-6 between the hyper- and the hypothyroid 
groups (Pc0.05 and PcO.Ol respectively). In heart, hyperthyroidism only resulted in an 
decrease in C18:2n-6 (PcO.Ol) while hypothyroidism produced increases in C17:ln-7 
(PcO.Ol) and C20:3n-6 (Pc0.05). The ratio of C20:4n-6/C18:2n-6 increased significantly 
in the hyperthyroid group (PcO.Ol). In addition, significant difference was found in 
C18:ln-7 (Pc0.05) and C20:4n-6 (PcO.Ol) between the hyper- and hypothyroid groups. It 
was evident that the variations in C20:4n-6/C18:2n-6 ratio observed in the nervous tissues 
were also present in kidney and heart. Actually, the opposite effects of thyroid status on 
the contents of C18:2n-6 and C20:4n-6 were more evident in kidney and heart than in the 
nervous tissues. Similar to the nervous tissues, no significant changes were found in the 
proportions of the major fatty acid classes and UI in different thyroid statuses. 
Comparisons of PL fatty acid composition in different thyroid statuses are shown in figure 
4.6.
Figure 4.6 Membrane fatty acid composition in different thyroid statuses
■ Hyperthyroid m Euthyroid □ Hypothyroid
(a) Brain
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(b) Spinal cord
(c) Sciatic nerve
Fatty acids
(d) Kidney
(e) Heart
The fatty acid compositions of tissue PL extracts were compared between different thyroid statuses. Black bars represent hyper- 
(n=7), gray for eu- (n=6) and white for hypothyroid (n=7) groups.
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Table 4.4 Membrane fatty acid composition in different thyroid statuses
Brain Spinal cord Sciatic nerve
Hyper Eu Hypo Hyper Eu Hypo Hyper Eu Hypo
C16:0 20.2±0.3 19.910.3 21.310.6 13.910.4 13.810.6 13..810.3 19.110.5 20.210.5 19.110.4
C17:0 0.310.0 0.310.1 0.310.1 0.510.1 0.810.3 0.610.3 1.010.2 1.510.4 0.710.2
Cl 8:0 19.710.3 1 8.310.5 18.910.3 12.510.3 12.210.5 12.510.5 8.810.3 8.110.5 8.010.4
C20:0 0.210.0 0.210.0 0.210.0 1.710.1 1.610.1 1.510.1 1.710.1 1.410.1 1.510.1
C22:0 0 0 0 0.710.1 0.710.1 0.710.1 0.310.1 0.210.1 0.110.1
C16:ln-7 1.410.1 1.310.1 1.410.1 1.210.2 1.310.3 1.510.2 2.910.5 2.010.1 2.910.5
C17:ln-7 1.710.2 1.710.1 2.110.4 1.410.4 2.010.6 2.510.5 1.510.4 2.810.9 2.410.7
C18:ln-7 4.510.1 4.710.2 4.310.2 6.410.3 6.910.2 6.810.2 2.710.5 1.810.6 1.710.6
C18:ln-9 19.410.4 20.010.3 20.010.5 31.310.7 31.510.3 31.010.5 45.011.2 45.111.3 47.911.5
C20:ln-9 1.210.1 1.510.2 1.210.1 12.510.4 11.510.3 11.710.6 0.910.1 1.010.2 1.010.2
C20:3n-9 0 0 0 0 0 0 0 0 0
C22:ln-9 0.110.0 0 0 0.510.0 0.510.0 0.510.0 0.210.0 0.210.0 0.210.1
C24:ln-9 0 0 0 0.110.1 0.110.0 0 0.210.1 0.110.0 0.210.0
C18:2n-6 0.610.0 0.610.0 0.810.0df 0.610.0 0.610.0 0.610.0 0.810.0 1.110.1 1.010.1
C18:3n-6 0 0 0 0.110.1 0 0 0 0 0
C20:2n-6 0.210.0 0.210.0 0.210.0 0.610.0 0.510.0 0.510.0 0.110.0 0.110.0 0.110.0
C20:3n-6 0.310.0 0.310.0 0.310.0 0.510.0b 0.410.0 0.410.0 0.410.0 0.410.0 0.410.0
C20:4n-6 11.510.3 10.510.5 10.2l0.2e 3.910.1 4.010.1 3.910.2 3.810.1 3.810.2 3.410.1
C22:4n-6 2.810.2 2.510.2 2.510.1 1.710.l b,f 1.410.1 1.410.1 0.810.0 0.910.1 0.710.0
C18:3n-3 0 0 0 0.310.1 0.210.0 0.210.0 0 0 0
C20:3n-3 0 0 0 0 0 0 0 0 0
C20:5n-3 0.110.0 0.510.3 0.110.0 1.110.1 1.110.1 1.110.1 4.010.2a 3.310.1 3.610.2
C22:3n-3 0.710.1 0.510.1 0.610.1 0.110.0 0 0.110.0 0 0 0
C22:5n-3 0.310.1 0.610.1 0.510.1 0.910.2 1.010.1 0.910.2 1.810.3 1.910.3 1.010.3
C22:6n-3 14.910.3 15.810.3 15.110.2 7.410.4 7.810.4 7.510.2 3.910.1 4.110.1 3.910.1
MUFA 28.210.6 29.810.6 29.110.5 53.410.9 53.810.8 54.110.9 53.410.8 52.910.8 56.210.7ce
PUFA 31.410.4 31.510.4 29.710.5ce 17.310.6 17.110.5 16.710.5 15.710.6 15.610.4 14.310.4
n-3 16.010.3 17.410.6 15.810.3 9.810.5 10.210.4 9.810.4 9.810.5 9.310.3 8.510.4
n-6 15.310.4 14.110.6 13.910.36 7.410.2 7.010.2 6.910.2 5.910.2 6.310.3 5.710.2
n-9 20.710.5 21.710.4 21.310.6 44.410.7 43.510.4 43.310.8 46.311.2 46.411.2 49.311.5
n-7 7.510.3 7.910.3 7.810.3 9.010.6 10.310.8 10.810.6 7.111.2 6.511.4
7.011.5
PU/MU 1.110.0 1.110.0 1.010.0 0.310.0 0.310.0 0.310.0 0.310.0 0.310.0 0.310.0
n-6/n-3 1.010.0 0.810.0 0.910.0 0.810.0 0.710.0 0.710.0 0.610.0 0.710.0 0.710.0
20:4/18:2 19.010.7 16.710.4 13.6i0.6df 7.010.5 6.610.4 6.310.3 4.610.3 3.710.3 3.510.3e
avCL 18.610.0 18.610.0 18.510.0 18.610.0 18.510.0 18.510.0 18.010.0 18.010.0 18.010.0
UI 181.411.6 184.811.9 179.112.8 136.012.4 137.012.2 135.211.9 127.512.1 126.111.6
123.011.9
Proportions of individual fatty acids are expressed area percentage of total identified fatty acids. Statistical significance at P<0.05 and 
PcO.Olare represented by “ and b (between the hyper- and euthyroid groups),c andd (between the hypo- and euthyroid groups), and 
(between the hyper- and hypothyroid groups) respectively.
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Table 4.4 Membrane fatty acid composition in different thyroid statuses (co n tin u ed )
Kidney Heart
Hyper Eu Hypo Hyper Eu Hypo
C16:0 19.7±0.3 19.010.6 18.010.3e 11.610.3 11.310.5 11.910.5
C17:0 0.510.1 0.410.0 0.410.0 0.510.1 0.410.0 0.510.1
C18:0 16.910.3 15.910.6 16.210.5 20.610.4 19.611.0 19.110.7
C20:0 0.210.0 0.210.0 0.310.0 0.210.0 0.210.0 0.310.0
C22:0 0 0 0 0 0 0
C16:ln-7 1.110.1 1.110.1 1.010.1 0.510.0 0.610.0 0.710.2
C17:ln-7 0.210. l b 0.610.1 0.410.1 0.510.1 0.510.1 0.810.2df
C18:ln-7 3.010.1 3.110.1 2.910.1 4.310.1 4.210.1 4.010.2e
C18:ln-9 8 .6 l0 .r f 9.410.2 9.910.3 5.310.3 6.610.4 6.010.4
C20:ln-9 0.210.0 0.310.1 0.310.1 0.410.1 0.610.3 0.510.3
C20:3n-9 0.210.0 0.210.0 0.210.0 0.110.0 0.110.0 0.110.0
C22:ln-9 0 0 0 0 0 0
C24:ln-9 0.210.1 0.110.0 0.110.0 0.210.1 0.210.1 0.210.1
C18:2n-6 9.010.3bf 10.810.3 13.710.3d,f 15.110.4bf 8.410.7 18.810.5
C18:3n-6 0.110.0 0.110.1 0.210.1 0.210.0 0.210.1 0.210.1
C20:2n-6 0.410.0 0.410.0 0.410.0 0.210.0 0.310.0 0.310.1
C20:3n-6 0.810.0 0.810.0 1.010.1 0.310.0 0.410.0 0.510. r f
C20:4n-6 32.210.5 30.410.7 28.210.9f 24.110.5 22.310.6 21.210.6f
C22:4n-6 0.510.0bf 0.410.0 0.410.0 0.810.0 0.710.0 0.810.0
C18:3n-3 0.110.0 0 0 0 0.110.1 0.110.1
C20:3n-3 0.310.1 0.210.1 0.210.1 0.110.0 0 0.110.1
C20:5n-3 0.510.0 0.510.1 0.710. l df 0.210.0 0.210.0 0.410.1
C22:3n-3 0.410.0 0.510.0 0.410.0 2.410.2 1.910.2 1.810.1
C22:5n-3 0.910.2 1.210.1 1.210.1 0.710.1 0.710.2 0.910.2
C22:6n-3 4.310.2 4.410.2 4.210.2 11.710.4 10.610.7 11.010.3
MUFA 13.110.2bf 14.610.3 14.410.2 11.110.4 12.610.8 12.210.8
PUFA 49.610.4 49.910.8 50.710.5 55.910.4 55.810.7 56.110.7
n-3 6.510.3 6.810.4 6.710.2 15.110.4 13.610.9 14.310.4
n-6 43.010.6 42.910.8 43.810.6 40.810.5 42.211.1 41.710.8
n-9 9.010.2a,f 10.010.3 10.410.3 5.910.4 7.510.8 6.710.5
n-7 4.310.2 4.510.2 4.310.2 5.310.2 5.210.2 5.510.4
PU/MU 3.8lO.Ob 3.410.0 3.510.1 5.110.2 4.510.2 4.710.3
n-6/n-3 6.810.4 6.510.4 6.610.3 2.710.1 3.210.3 2.910.1
20:4/18:2 3.610.2bf 2.810.1 2.110.1df 1.610.1bf 1.210.1 1.110.0
avCL 18.510.0 18.510.0 18.510.0 18.910.0 18.810.0 18.810.0
UI 201.311.7 200.313.2 197.512.5 225.311.4 218.013.9 218.713.0
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4.2.7 Relationship between thyroid status, molecular activity o f the sodium pump, and 
membrane fatty acid composition
Correlation was explored between thyroid hormone concentrations and sodium pump 
concentration, Na+-K+-ATPase activity and sodium pump molecular activity in the tissues 
(see figure 4.7). No significant correlation was found between sodium pump concentration, 
Na+-K+-ATPase activity, sodium pump molecular activity and plasma concentration of 
either T3 or T4 in brain, spinal cord and sciatic nerve. In contrast to the nervous tissues, in 
the kidney, sodium pump concentration and Na+-K+-ATPase activity were positively 
correlated while sodium pump molecular activity was negatively correlated with T3 and T4 
concentrations. Heart demonstrated the positive correlation between sodium pump 
concentration, Na+-K+-ATPase activity and hormone concentrations, but no significant 
correlation between sodium pump molecular activity and hormone concentrations.
In addition, correlation was examined between hormone concentrations and the ratio of 
C20:4n-6/C18:2n-6, the most common and evident change in membrane fatty acid 
composition (see figure 4.8). A positive correlation was found between C20:4n-6/C18.2n-6 
ratio and plasma concentrations of T3 and T4 in brain (P<0.01). In spinal cord and sciatic 
nerve, the ratio of C20:4n-6/C18:2n-6 was positively correlated to T3 concentration 
(P<0.01 and 0.0001 respectively) but not to T4 concentration. Similar positive correlation 
between C20:4n-6/C18:2n-6 ratio and concentrations of T3 and T4 was also found in 
kidney and heart (P<0.0001). No significant correlation was found between sodium pump 
molecular activity and C20;4n-6/C18i2n-6 ratio in the tissues (see figure 4.9).
Figure 4.7 Relationship between sodium pump concentration, Na+-K+-ATPase activity, molecular
activity of the sodium pump and thyroid status
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Relationship between sodium pump concentration, Na+-K+-ATPase activity and sodium pump molecular activity and 
plasma concentrations of T3 and T4. Regression line and respective r and P values are shown in each graph. No 
significant correlation was found with concentration of either hormone in brain, spinal cord and sciatic nerve. In kidney, 
however, both sodium pump concentration and Na+-K+-ATPase activity were positively correlated with concentrations of 
both hormones, whereas sodium pump molecular activity was negatively correlated with both hormones. In heart, similar 
positive correlation was found between sodium pump concentration, Na+-K+-ATPase activity and both T3 and T4 
concentrations, but no significant correlation was present between sodium pump molecular activity and hormone 
concentrations.
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Figure 4.8 Relationship between C20:4n-6/C18:2n-6 ratio of membrane 
fatty acid composition and thyroid status
♦ Hyperthyroid ■ Euthyroid ▲ Hypothryoid
(a) B ra in
30
(b ) S p in a l co rd
1 1.5
T3 (nmol/L) T4 (nmol/L)
1 1.5
T3 (nmol/L)
(c) S c ia tic  n e rv e
2.50.5
(d ) K id n e y
62
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Relationship between plasma concentrations of T3 and T4 and C20:4n-6/C18:2n-6 ratio of membrane fatty acid 
composition. Regression line and respective r and P values are shown in each graph. Positive correlation was found with 
concentrations of both T3 and T4 in brain, kidney and heart. In spinal cord and sciatic nerve, positive correlation was 
present between C20:4n-6/C18:2n-6 ratio and concentration of T3 but not T4.
Figure 4.9 Relationship between molecular activity of the sodium pump and 
C20:4n-6/C18:2n-6 ratio of membrane fatty acid composition
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Relationship between sodium pump molecular activity and C20:4n-6/C18:2n-6 ratio of membrane fatty acid composition. 
Regression line and respective r and P values are shown in each graph. No significant correlation was found between 
sodium pump molecular activity and C20:4n-6/C18:2n-6 ratio of membrane fatty acid composition.
4.3 Discussion
This study examined the influence of thyroid status on sodium pump concentration, Na+- 
K+-ATPase activity and sodium pump molecular activity, and also on the membrane fatty 
acid composition in three nervous tissues (brain, spinal cord and sciatic nerve) and two 
non-nervous tissues (kidney and heart). In summary, all the nervous tissues displayed 
unresponsiveness (or resistance) to change in systemic thyroid status in terms of sodium 
pump concentration, Na+-K+-ATPase activity and sodium pump molecular activity. In 
contrast, kidney and heart responded to different thyroid statuses with significant changes 
in sodium pump concentration and Na+-K+-ATPase activity. In terms of sodium pump 
molecular activity, no significant variation was found between different thyroid statuses in 
kidney and heart except an increase in hypothyroidism in kidney (P<0.05). On the other 
hand, different thyroid statuses resulted in various slight variations in membrane fatty acid 
composition in these tissues. Variations in the ratio of C20:4n-6/C18.2n-6 (increase in 
hyper- and decrease in hypothyroidism) were observed in all the tissues. Analysis of 
correlation revealed that, in nervous tissues, the C20:4n-6/C18:2n-6 ratio was positively 
correlated with plasma thyroid hormone concentrations (mainly T3, correlation with T4 
only present in brain). In contrast, a positive correlation was found in kidney and heart 
between thyroid hormone concentrations (both T3 and T4) and sodium pump concentration, 
Na+-K+-ATPase activity and 20:4n-6/C18:2n-6 ratio. Furthermore, a negative correlation 
was found in kidney between sodium pump molecular activity and thyroid hormone
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concentrations. However, no significant correlation was found between sodium pump 
molecular activity and C20:4n-6/C18:2n-6 ratio of membrane fatty acid composition.
The observation that sodium pump concentration and Na+-K+-ATPase activity are 
positively related to thyroid status in kidney and heart is consistent with similar 
observations in early studies (Lin & Akera 1978; Lin & Tang 1997; Kamitani et al 1992). 
Thyroid hormones are known to induce the transcription of sodium pump genes (Hulbert 
2000). This induction appears to be a secondary response to increased membrane 
permeability to K+ and Na+ as time course studies have revealed that increased passive 
leaks of Na+ and K+ precede an increase in sodium pump number (Everts & Clausen 1988). 
Furthermore, thyroid hormones have been shown to increase both the electrical activity 
and number of Na+ channel in skeletal muscle (Harrison & Clausen 1998; Brodie & 
Sampson 1989). In rat liver treated with low dose of T3 (1 Bg/100g bw), an increase was 
observed in Rb+ (a K+ analog) efflux without increase in either sodium pump concentration 
or Na+-K+-ATPase activity (Haber & Loeb 1986). Therefore, it is likely that increases in 
Na+ and K+ leaks and the invoked increase in sodium pump activity trigger the induction of 
sodium pump genes. However, the molecular basis for the increased Na+ and K+ leaks and 
channel up-regulation is not clear. For the decreased number of sodium pump in 
hypothyroidism, decrease in amount of mRNAs has been found along with decrease in 
protein, suggesting the involvement of transcriptional regulation (Horowitz et al 1990). As 
the increase in mRNA is far greater than the increase in protein level, it is possible that 
regulation at post-transcriptional level is also involved.
The induction of sodium pump by thyroid hormones has been found to be isoform-specific 
(Haber & Loeb 1988). However, the responsive isoforms in different tissues are different. 
In hypothyroid rats treated with T3, kidney displayed increase in a i and Pi subunits, while 
in skeletal muscle the induced isoforms were 0C2 and P2 (Azuma et al 1993). T3 treatment 
induces all three isoforms with varied time courses in culture of myocardial cells 
(Kamitani et al 1992). Similarly, the decrease in sodium pump concentration induced by 
hypothyroidism in kidney and heart also appeared isoform-specific (Horowitz et al 1990). 
However, little is known about the molecular basis underneath this selectivity.
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Obviously, the variations in Na+-K+-ATPase activity are related to changes in sodium 
pump number in different thyroid statuses. In kidney, sodium pump molecular activity also 
contributed to the increase in Na+-K+-ATPase activity. This is evidenced by the slopes of 
the regression lines of Na+-K+-ATPase activity, sodium pump concentration and molecular 
activity against hormone concentrations (see figure 4.7-d). In the present study, a negative 
correlation has been found in kidney between sodium pump molecular activity and thyroid 
hormone concentrations (P<0.05 for T3 and P<0.01 for T4). A similar but statistically 
insignificant trend is also present in heart. This is the first time sodium pump molecular 
activity has been found related to, and possibly regulated by, thyroid status. Furthermore, 
this is also the first time sodium pump molecular activity has been considered to be 
involved in the regulation of sodium pump by thyroid status. Since the induction and 
suppression of sodium pump transcription in hyper- and hypothyroidism respectively are 
both isoform-specific, this variation in sodium pump molecular activity may result from a 
shift in isoform abundance caused by changing thyroid status. Alternatively, thyroid status 
may regulate sodium pump molecular activity by changing membrane lipid composition, 
which has been proposed to modify sodium pump molecular activity (Hulbert & Else 
1999, 2000).
The lack of response in brain observed in the present study is consistent with previous 
studies. Treatment of cultured brain cells (mixed population) with thyroid hormone failed 
to produce any change in sodium pump concentration and Na+-K+-ATPase activity 
(Atterwill et al 1985). In another study (Lin & Akera 1978), in vivo T3 treatment in rat 
showed no effect on sodium pump concentration in brain, in contrast to significant increase 
in liver, kidney and skeletal muscle. Horowitz et al (1990) also showed no decrease in 
either mRNA amount or sodium pump number in brain in hypothyroidism, compared to 
significant reduction in kidney, heart and skeletal muscle. This lack of response in brain 
has been linked to the characteristic local distribution of deiodinases, which functions to 
maintain local T3 concentration at steady level (Hulbert 2000). In hyperthyroidism, the 
locally abundant D2 is inhibited and production of T3 is reduced so that brain takes more 
T3 produced elsewhere (e.g. kidney, heart and liver). In hypothyroidism, D2 is stimulated
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so that the local production of T3 is increased (refer to section 1.2.1). Therefore, the local 
deiodinase system in brain functions to buffer the impact of changing systemic thyroid 
status. Determination of local thyroid hormone concentration will be helpful to explain the 
apparent unresponsiveness observed in brain. An interesting fact about brain is that a 
dramatic change takes place at neonatal stage in terms of thyroid responsiveness: Na+-K+- 
ATPase responds to thyroid hormones in neonatal brain but the response disappears 
between 15~22-day after birth (Schmitt & McDonough 1988). It would be of interest to 
measure the activities of deiodinases in neonatal brain and characterize the development of 
the brain deiodinase system.
Little information is available in literature about the influence of systemic thyroid status on 
the sodium pump in spinal cord and peripheral nerves. One study has observed that no 
significant change was generated in sodium pump concentration (P>0.05) in rat sciatic 
nerve by changing thyroid status (Kjeldsen & Npgaard 1987), which is consistent with the 
results of the present study. The present study has demonstrated that both spinal cord and 
sciatic nerve displayed constant sodium pump concentration, Na+-K+-ATPase activity and 
sodium pump molecular activity in response to changed systemic thyroid status. Since D2 
is predominantly present in CNS (St. Germain & Galton 1997), the homeostatic deiodinase 
system may also exist in spinal cord. However, it is not known whether a similar system is 
present in peripheral nerves. Determination of local hormone concentrations in spinal cord 
and sciatic nerve would be helpful to elucidate their apparent resistance.
Previous studies have demonstrated that thyroid status can influence membrane lipid 
composition in a number of ways, such as cholesterol (CL) content, CL/PL ratio, 
composition of PL classes and fatty acid composition (Szymanska et al 1991; Hoch 1988). 
Regarding the influence on the fatty acid composition of PL, some of the effects result 
from changes in fatty acid proportions in one or more PL classes, while others from a shift 
in the proportion of PL classes that have distinctive fatty acid composition (Hoch et al 
1981). Although the effects of thyroid status on PL fatty acid composition are highly 
varied and complex, one consistent change present in most studies is the shift in n-6 PUFA 
with thyroid status (Hulbert 2000). In microsomal, mitochondrial and sarcolemmal
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membranes of liver and heart, hyperthyroidism results in a decrease in C18:2n-6 and 
increase in C20:4n-6 along with increased ratio of C20:4n-6/C18:2n-6 (Faas & Carter 
1981; Ruggiero et al 1984; Shaw & Hoch 1977), whereas hypothyroidism result in an 
increase in C18:2n-6 and decrease in C20:4n-6 along with decreased C20:4n-6/C18:2n-6 
ratio (Hoch et al 1981; Faas & Carter 1982; Pehowich 1995). Consistent with these earlier 
studies, similar changes were observed in the ratio of C20:4n-6/C18:2n-6 in different 
thyroid statuses in kidney and heart, although the contents of C18:2n-6 and C20:4n-6 
responded less evidently (see table 4.4). The positive correlation between C20:4n- 
6/C18:2n-6 ratio and thyroid hormone concentrations suggests that thyroid status may 
regulate the activities of A6 and A5 desaturases that are involved in this conversion. The 
process of conversion is schematically shown below.
Linoleic acid (18:2, A9,12) Arachidonic acid (20:4, A5,8,11,14)
j  A6 desaturase t A5 desaturase
y-Linolenic acid (18:3, A6,9,12) -----------------► homo-y-linolenic acid (20:3, A8,11,14)
elongase
A study on enzyme dynamics has revealed that in rat liver microsomes both A6 and A5 
desaturases are regulated by thyroid status (Hoch 1988). The Vmax of A6 desaturase 
decreases in hypothryoidism while Km decreases in hyperthyroidism. For A5, 
hypothyroidism reduces V^x but hyperthyroidism enhanced it.
Consistent with the observations from a previous study (Tacconi et al 1991) where 
hypothyroidism failed to produce any change in C18:2n-6 and C20:4n-6 in brain 
microsomal and mitochondrail membranes, changing thyroid status did not cause 
significant variations in the contents of C18:2n-6 and C20:4n-6 in the nervous tissues of 
the present study (except an increase in C18:2n-6 in hypothyroid brain). In terms of the 
ratio of C20:4n-6/C18:2n-6, positive correlation with T3 concentration was present in all 
the three nervous tissues while positive correlation with T4 concentration only present in 
brain, suggesting the regulation of desaturase activity by thyroid status may also exist in 
the nervous tissues. Compared to kidney and heart, nervous tissues demonstrated less 
responsive to changing systemic thyroid status in terms of membrane fatty acid
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composition (as evidenced by the slopes of the regression lines, see figure 4.8). Lower 
responsiveness of brain, and probably spinal cord, in membrane fatty acid composition 
could also be related to the homeostatic deiodinase system present in brain as discussed 
above. The relatively euthyroid local status makes them less responsive (or sensitive) to 
changes in systemic thyroid status. In addition, it is noticed that A6 desaturase activity is 
high in fetal brain but reduces markedly at about 20 days after birth. This time course 
coincides perfectly with the reduction in responsiveness for sodium pump as discussed 
above. It is not known what lead to this change in thyroid responsiveness at this particular 
stage of development.
Consistent with previous findings (Hulbert 2000), no influence of thyroid status has been 
found on the content of n-3 PUFAs in the present study. No significant changes were 
found in overall unsaturation (UI) of membrane fatty acid composition by thyroid status in 
any of the tissues in the present study. This is contrary to other studies where elevation of 
UI was observed in hyperthyroidism in cardiac sarcolemma (Szymanska et al 1991). These 
variations in results are likely to result from different tissue preparations used. It has been 
noticed that plasma membrane fatty acid composition may respond differently from 
organelle membranes (Hoch 1988).
From the results of this study, no evidence was obtained indicating that thyroid hormones 
achieve their effects on sodium pump via modification of membrane fatty acid 
composition. Changes in C20:4n-6/C18:2n-6 ratio were present in both responsive tissues 
(kidney and heart) and unresponsive tissues (brain, spinal cord and sciatic nerve). 
Furthermore, no significant correlation was found between sodium pump molecular 
activity and C20:4n-6/C18:2n-6 ratio. However, as mentioned above, different membranes 
may respond differently to change in thyroid status (Hoch 1988), so it is possible that 
changes in fatty acid composition of the plasma membrane might be counteracted by 
opposite changes in other membrane components. Purified plasma membrane would be 
preferable for use in future studies in this area. Alternatively, thyroid status could also 
influence sodium pump molecular activity by regulation of other components of 
membrane. One likely candidate is cholesterol (CL), a major determinant of membrane
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fluidity. Molecular activity of the sodium pump has been demonstrated to be negatively 
correlated to the ratio of CL/PL of membrane (Wu 2000). On the other hand, influences of 
thyroid status on membrane cholesterol content have been observed in a number of tissues, 
although the effects are varied and contradictory (Hulbert 2000). Effects on cholesterol 
would be another area of interest in elucidation of the mechanism by which thyroid status 
modifies sodium pump molecular activity.
Finally, it should be noted that, despite the obvious association, unchanging sodium pump 
molecular activity might not necessarily reflect constant sodium pump activity in different 
thyroid statuses in nervous tissues as workrates of sodium pump in living cells are far 
lower than its maximum capacity represented by molecular activity. For example, sodium 
pump activity measured by K+ (i.e. Rb+) uptake is 1.89±0.39 (imol/g tissue.min 1 in rat 
kidney cortex tissue slices, assuming a 1:1 ratio of Rb+ uptake:K+ uptake (Couture & 
Hulbert 1995b). If using the sodium pump concentration result in the present study, the 
pumping activity of a single sodium pump would be 630 K+/min in rat kidney cortex. 
Assuming hydrolysis of 1 ATP for every 2 K+ pumped across membrane, sodium pump in 
rat kidney cortex is working at only 1% of its molecular activity. A similar low percentage 
could be obtained for the sodium pump in rat liver at about 10% (Else et al 1996; Couture 
& Hulbert 1995b). Therefore, stimulation of sodium pump activity does not have to 
involve induction of sodium pump or increase in Na+-K+-ATPase activity. It is possible 
that sodium pump activity is regulated by adjusting the percentage of molecular activity 
used in different thyroid statuses. Actually, Atterwill et al (1985) observed stimulation of 
sodium pump activity by thyroid hormone treatment as measured by Rb+ uptake. However, 
they failed to link this regulation to thyroid hormones. Determination of sodium pump 
activity in living cells in different thyroid statuses in future studies will shed more light on 
the responsiveness of the tissues to thyroid status.
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Appendix I Na+-K+-ATPase activity of toad tissues at 25°C 
and 37°C & Qio values
Na+-K+-ATPase activity (pmol Pi/mg T*hr'1)
Qio25°C 37°C
Brain 0.69±0.09 1.11 ±0.08 1.48
Spinal cord 0.37±0.07 0.86±0.05 2.04
Sciatic nerve 0.06±0.01 0.08±0.01 1.35
Kidney 0.56±0.07 1,08±0.07 1.71
Heart 0.18±0.02 0.25±0.02 1.34
Appendix II Dissociation constant ( K d ) and maximum binding (Bm ax) of r a t  
and toad tissues estimated from binding isotherms
Rat Toad
O ne-s ite T w o-site
O ne-site
Kd Bmax Kd(L) Bm ax(L) Kd(H) Bmax (H )
K d Bmax
(pM ) (pm ol/g) (pM ) (pm ol/g) (pM ) (pm ol/g)
(pM ) (pm ol/g)
B rain 10.4 5,800
2.2 18,500
Spina l cord 10.5 4,200
10.8 13,000
S cia tic  nerve 12.1 1,400
16.0 1,100
K idney 19.6 2,700
3.5 1,000 13.3 12,300
H eart 26.4 700
6.9 500 10.9 900
In b ind ing  iso therm s, values were estim ated by the saturated level(s) o f b inding, and KD values by the 
concen tra tion  at w hich  h a lf  o f  w as achieved. L  and H in parenthesis represent low - and high-affinity 
b ind ing  respectively  in rat k idney and heart w here tw o saturation levels, presum ably  standing for two binding
sites, w ere identified .
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